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Abstract
Damage in composite materials spans many length scales and is often difficult to detect
or costly to repair. The incorporation of self-healing functionality in composite materials
has the potential to greatly extend material lifetime and reliability. Although there has
been remarkable progress in self-healing polymers over the the past decade, self-repair in
fiber-reinforced composite materials presents significant technical challenges due to strin-
gent manufacturing and performance requirements. For high performance, fiber-reinforced
composites, the self-healing components need to survive high temperature processing, reside
in matrix interstitial regions to retain a high fiber volume fraction, and have minimal im-
pact on the mechanical properties of the host material. This dissertation explores several
microencapsulated solvent-based self-healing approaches for fiber-reinforced composites at
the fiber/ matrix interface size scale as well as matrix cracking. Systems are initially devel-
oped for room temperature cured epoxies/ glass fiber interfaces and successfully transitioned
to carbon fibers and high temperature-cured, thermoplastic-toughened matrices.
Full recovery of interfacial bond strength after complete fiber/matrix debonding is achieved
with a microencapsulated solvent-based healing chemistry. The surface of a glass fiber is
functionalized with microcapsules containing varying concentrations of reactive epoxy resin
and ethyl phenyl acetate (EPA) solvent. Microbond specimens consisting of a single fiber
and a microdroplet of epoxy are cured at 35◦C, tested, and the interfacial shear strengths
(IFSS) during the initial (virgin) debonding and subsequent healing events are measured.
Debonding of the fiber/matrix interface ruptures the capsules, releasing resin and solvent
into the crack plane. The solvent swells the matrix, initiating transport of residual amine
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functionality for further curing with the epoxy resin delivered to the crack plane. Using
a resin-solvent ratio of 3:97, a maximum of 100% IFSS recovery is achieved– a significant
enhancement over prior work that reported 44% average recovery of IFSS with microencap-
sulated dicyclopentadiene (DCPD) monomer and Grubbs’ 1st Generation catalyst healing
agents. The effects of capsule coverage, resin-solvent ratio, and capsule size on recovery of
IFSS are also determined, providing guidelines for integration of this healing system into
high fiber volume fraction structural composites. High healing efficiencies are achieved with
capsules as small as 0.6 µm average diameter.
The resin-solvent healing system is then extended to repair of a carbon fiber/epoxy
interfacial bond. A binder is necessary to improve the retention of capsules on the carbon
fiber surface. Two different methods for applying a binder to a carbon fiber surface are
investigated. Healing efficiency is assessed by recovery of IFSS of a single functionalized fiber
embedded in an epoxy microbond specimen. The two binder protocols produce comparable
results, both yielding higher recovery of IFSS than samples prepared without a binder. A
maximum of 91% recovery of IFSS is achieved.
In the next study, the resin-solvent healing system is applied to both interfacial dam-
age and matrix cracking in a model composite specimen, consisting of discrete fiber tows
embedded in a room temperature cured epoxy. Glass fiber tows are precisely placed in a
compact tension specimen for controlled crack growth. The progression of matrix cracking
and fiber debonding is observed optically during testing. Healing potential is assessed by
injection of the healing agents into reference specimens (no capsules). The area under the
load-displacement curve recovered during the healing event serves as a metric for evaluation
of healing performance. Though full recovery is achieved in neat epoxy specimens, healing
efficiency in multi-tow specimens is limited to 50%, due to the larger crack separations and
energy lost during fiber fracture. In the case of only a singular embedded fiber tow, healing
efficiency increases to an average of 83% recovery with full recovery in several samples. Ad-
ditionally, microcapsules are incorporated into the compact tension specimen and along the
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fiber tow interface to evaluate in situ healing.
Several strategies to improve microcapsule thermal stability are investigated in order to
transition solvent-based healing to high temperature cured material systems. A double shell
wall technique is adopted for several different size scales of microcapsules. First, the effect of
the inner polyurethane (PU) shell wall thickness on thermal stability is evaluated. Though
high thermal stability at 180◦C is achieved for large (ca. 150 µm in diameter) capsules,
smaller capsules (> 2 µm in diameter) suffer from increased core loss. The addition of
certain core thickeners improves thermal stability for small capsules (ca. 20% increase in
core retention) when compared to capsules with solvent alone. However, an additional
poly(dopamine) coating leads to the greatest improvement in thermal stability, with nearly
full retention of the core solvent for all capsule size scales.
Finally, a thermoplastic resin poly(bisphenol A-co-epichlorohydrin), PBAE, is blended
with a high glass transition temperature (Tg) epoxy matrix to simultaneously toughen and
act as a healing agent in combination with encapsulated solvents. Microcapsules are coated
with poly(dopamine) to improve the thermal stability and retain the core solvent during
a cure cycle at 180◦C. The fracture toughness of the high Tg epoxy (EPON 828: diamino
diphenyl sulfone) is doubled by the addition of 20 wt % PBAE alone and tripled by the
addition of both microcapsules and the thermoplastic phase. Self-healing is achieved with
up to 57% recovery of fracture toughness of the toughened epoxy. Healing performance and
fracture toughness of the microcapsule containing material remain stable after aging 30 days.
The relative amounts of thermoplastic phase and the presence of solvent-filled microcapsules
influence the storage modulus, Tg, and healing performance of the polymer.
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Chapter 1
Introduction
The heterogeneous microstructure of fiber-reinforced composites leads to complex damage
modes that are difficult to detect and costly to repair. Although there has been remarkable
progress in self-healing polymers over the past decade, the ability to repair damage in fiber-
reinforced composites continues to present significant technical challenges. Self-healing in
fiber-reinforced composites has stringent requirements which include: seamless integration
with the fiber architecture, survival of the manufacturing process, and retention of original
mechanical properties.
1.1 Approaches to Self-healing Materials
Three different healing approaches have emerged for polymers and fiber-reinforced polymer
composites: (1) capsule-based delivery of healing agents, (2) microvascular-based delivery
of healing agents, and (3) thermally-induced intrinsic healing (Figure 1.1). Each approach
differs by the size scale of damage addressed and the mechanism used to sequester the
healing functionality until triggered by damage [1]. Capsule based self-healing strategies
rely on damage triggered release of healing agents stored within a polymeric shell wall and
have been successfully applied to bulk polymers [2–33], polymer coatings [34–38], fiber-
reinforced polymeric composites [39–50], and cementitious materials [51]. After release, the
local healing agent is depleted, leading to only a singular, local healing event. The diameter
of the capsule dictates the volume of healing agent available and consequently the size of
damage that can be addressed with this method [8]. Thus, capsule approaches are well-suited
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for damage where the crack separation is less than 100 µm.
In vascular self-healing materials, healing agents are delivered to a damage site by a net-
work of capillaries or hollow channels, which may be interconnected one-dimensionally (1D),
two-dimensionally (2D), or three-dimensionally (3D) [52–64]. The ability to circulate and
replenish healing agents enables multiple healing cycles of relatively large damage volumes
(> 100 µm).
Figure 1.1: Three major classifications of synthetic self-healing systems: (a) capsule-based
where reactive liquid healing agents (red/blue) are sequestered within a shell wall, (b) vas-
cular systems where healing agents are delivered through a network of refillable channels, (c)
intrinsic which utilize reversible chemical bonds to incorporate healing functionality directly
into the material [1].
Intrinsic self-healing materials do not have a sequestered healing agent but possess a
latent self-healing functionality that is activated by damage or by an external stimulus.
Bergman and Wudl [65] have reviewed both covalent and non-covalent based intrinsic healing
in polymers. One of the most studied examples of an intrinsic covalent-bond healing scheme
relies on thermoreversible Diels-Alder reactions [66–70]. Intrinsic healing in supramolecu-
lar polymers depends on non-covalent interactions such as hydrogen bonding, metal-ligand
bonds, and ionomeric bonding [71–76]. The bonding is reversible and these materials are
capable of multiple healing cycles, but often require small crack separations and additional
energy such as heat, pressure, or light.
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1.2 Capsule-based Self-healing
Advantages of the microcapsule approach over other techniques include complete autonomy
of the healing event, well understood methods for integration of spherical particulates in
polymer materials, and the ability to produce microcapsules with a wide range of diameters.
Capsule-based healing approaches can be divided into four categories: single capsule + cata-
lyst [2–14, 40–44, 47], multi-capsule [15–22, 24–26, 49], single capsule + latent functionality
[27–30, 48, 50], and single capsule + phase separation [31, 34, 37] (Figure 1.2).
1  Capsule-catalyst
a
2  Multicapsule
3  Latent functionality 4  Phase separation
1
1 1
1
2
2
2
2
mμ 003mμ 002
mμ 05mμ 001
Grubbs’
catalyst
PolyDCPD
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Figure 1.2: Four categories of self-healing capsule systems [1].
The capsule + catalyst approach has been demonstrated in a few cases for epoxy/catalyst
based systems [42, 43], with an extensive body of work on the dicyclopentadiene (DCPD)-
Grubbs’ catalyst system. In this approach a monomer is encapsulated and the interaction
of this monomer with a catalyst triggers polymerization in the crack plane. White et al. [2]
first employed this capsule + catalyst approach by embedding DCPD filled microcapsules
and Grubbs’ 1st Generation catalyst in an epoxy matrix. This healing chemistry was further
applied to both composite materials and repair of interfaces. Despite the benefits of this
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healing chemistry, including room temperature reaction kinetics and ease of encapsulation,
the catalyst was not stable at high temperatures and bonding was poor between epoxy and
poly(DCPD).
The dual capsule approach is an alternative to the capsule-catalyst strategy, in which
two components, protected separately by the microcapsule shell, come into contact and
polymerize [17, 19, 22, 24]. Recently, Jin et al. [24] reported healing efficiencies up to 60%
using an amine and epoxy resin separately encapsulated inside an epoxy matrix exposed to
a postcure temperature of 177◦C (Figure 1.3a). High temperature cure cycles improve the
mechanical properties of composite materials, and the ability to demonstrate crack healing
after exposure to such a cure cycle is a significant advancement. Although the Tg of the
epoxy was high (> 200◦C), the fracture toughness of the epoxy was only ca. 0.6 MPa m0.5.
Jin et al. also addressed a secondary concern for microcapsule-based systems: long term
capsule stability. For samples exposed to both a postcure at 121◦C and 150◦C, healing
efficiency was not reduced after aging up to 6 months (Figure 1.3b).
Figure 1.3: Example of a dual capsule system with a separately encapsulated amine and
epoxy. (a) Effect of capsule concentration on healing efficiency for three different cure cycles
with postcure temperatures ranging from 121◦C to 177◦C. (b) Healing efficiency after aging
at room temperature for up to 6 months [24].
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A third type of capsule healing system relies on latent functionality in the matrix and
offers a somewhat simpler solution by removing the necessity for two types of capsules.
Caruso et al. [27] achieved full recovery of fracture toughness in a slightly undercured
epoxy matrix with a single capsule containing a co-encapsulated resin and solvent. The
solvent swelled the matrix, initiating transport of residual amine functionality to cure the
co-encapsulated epoxy resin delivered to the crack plane. Healing efficiency was maximized
by varying the amount of resin delivered (Figure 1.4a). Caruso et al. also investigated the
stability of the healing system over time, but unfortunately found a 20% or more reduction
in healing performance after 30 days as the matrix reached a fully cured state (Figure 1.4b).
(a) (b)
Figure 1.4: Example of a latent functionality capsule system where the capsule contained
EPA solvent and a co-encapsualted epoxy. Latent functionality in the matrix (EPON 828:
DETA) was achieved by slightly under curing the matrix material. (a) Healing efficiency as
a function of encapsulated epoxy delivered showing a maximum of 120% recovery of fracture
toughness. (b) Healing efficiency as a function of days at room temperature showing a
gradual loss in healing performance as the matrix loses its residual functionality [27].
The fourth capsule strategy is based on phase separation. In this method, two healing
agents are incorporated into a material. One is protected by phase separation caused by a
lack of solubility in the host material [37]. The second healing agent is incorporated inside
a microcapsule, or in some cases is added by an external stimulus such as heat. Cho et al.
[34] incorporated a PDMS healing chemistry into a vinyl ester matrix and achieved up to
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24% recovery of fracture toughness. Due to the stability of the PDMS chemistry, higher cure
temperatures (50◦C) were possible as well as healing in high humidity conditions.
Recently, thermoplastics, which can phase separate out of an epoxy matrix, have been
used in combination with heat to repair fracture damage [77–80]. Hayes et al. blended a
thermoplastic, poly(bisphenol A-co-epichlorohydrin), with an epoxy, cured at 130◦C, and
achieved ca. 75% recovery of fracture toughness. Hayes et al. also incorporated a thermo-
plastic/ epoxy blend into a composite and achieved a 30% reduction in impact damage [77].
Luo et al. induced healing with a poly(caprolactone) (PCL) thermoplastic embedded in an
epoxy matrix after exposure to 190◦C for 8 min [79]. Luo and co-workers next developed
shape memory assisted self-healing with the same thermoplastic (PCL). The shape memory
alloys were activated by exposure to 80◦C, both rebonding and closing the crack. Both of
these systems are excellent examples of healing using a thermoplastic phase, but with the
limitation of requiring an external thermal stimuli.
1.3 Capsule-based Healing in Fiber- reinforced
Composites
Capsule-based strategies have been used to heal microcracking and delamination damage
in woven fiber-reinforced composites [40, 46, 47, 49]. Damage in fiber-reinforced composite
materials is complex and spans many length scales. The size scale of the damage often
dictates the approach adopted to repair that damage. Figure 1.5 shows several common
damage modes in composites and matches the size scale of that damage to an appropriate self-
healing approach. Capsule-based healing is most suitable for crack damage with separations
less than 100 µm, since capsules have a limited volume of healing agent to fill the damage
zone.
The work by Kessler et al. [40] is one of the first examples of a microcapsule-based
approach in a fiber-reinforced composite. Using a DCPD/ Grubbs’ healing chemistry, a
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Figure 1.5: Representative images of damage modes in composite materials and typical sizes
for these damage modes. The images show interfacial debonding as the smallest size scale
up to transverse cracking and then delaminations that can be as large as 1 mm in size. The
suitability of a particular healing approach is strongly tied to the size scale of the damage
volume.
maximum of 45% recovery of fracture toughness was achieved after 48 h at room temper-
ature. By elevating the healing temperature to 80◦C, healing was improved to 80%. The
microcapsules were large enough (ca. 150 µm in diameter) to deliver sufficient healing agent
to fill the damage volume. However, the capsules resided in matrix-rich regions, which re-
duced the local fiber volume fraction, compromising composite mechanical properties. Also,
the large capsule size limited access of the healing agents to the interior of the fiber tows.
A similar effect was observed by Moll et al. [49] (Figure 1.6). By incorporating a dual-
capsule PDMS healing chemistry, Moll and co-workers effectively sealed crack damage in a
composite, but mechanical properties suffered.
Reduction of the microcapsule size (to ca. 1-2 µm in diameter) would allow higher volume
fractions of fibers to be achieved in composite materials [9]. Smaller microcapsules are
suitable to repair interfacial damage since the crack separation associated with fiber/matrix
interfacial debonding is minimal. Moreover, interfacial damage is a critical damage mode
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Figure 1.6: Example of microcapsules residing in the interstitial resin-rich regions in a woven
glass fiber composite material, from Moll et al. [49].
that (a) leads to a loss in stiffness and strength [44] and (b) can coalesce to form larger
scale damage such as macroscopic cracking [40]. Therefore, the incorporation of healing
functionality at the fiber/ matrix interface is both a method to maintain superior mechanical
properties in a self-healing composite and hinder the development of larger scale damage.
1.4 Overview and Outline of Dissertation
In this research, several microencapsulated solvent-based healing strategies were investigated
for use in high performance fiber-reinforced composite materials. Initially, self-healing of
interfacial damage is targeted in a room temperature-cured, single fiber microbond specimen.
In later work, fiber debonding and matrix cracking in a model composite specimen are
explored. Finally, solvent healing is applied to a fully cured thermoplastic-toughened epoxy
cured at 180◦C.
Chapter 2 outlines the application of a solvent-based healing chemistry to repair a glass
fiber/ epoxy interfacial bond. A protocol was developed to autonomously repair the inter-
face using a single fiber microbond specimen. Repair of interfaces was demonstrated by
functionalizing microcapsules filled with a reactive resin-solvent healing agent directly onto
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the surface of a fiber. Full recovery of interfacial shear strength (IFSS) was achieved.
The successful resin-solvent healing chemistry is further extended to autonomous repair
of carbon fiber/ epoxy interfaces in Chapter 3. The reduction in fiber size, when compared
to glass fibers, required nanocapsules. In contrast to the electrostatic attraction of capsules
to glass fibers, the nanocapsules lacked affinity for the carbon fibers, which required devel-
opment of a binder protocol. Two binder protocols were explored and up to 91% recovery
of IFSS was achieved.
In Chapter 4, healing of interfacial debonding and matrix cracking was investigated in a
model composite consisting of discrete fiber tows in an epoxy resin. This protocol aims to
link single fiber microbond specimens, the most basic model composite, to characterization
of full composites. The interaction of fiber tow debonding and matrix cracking is studied.
The protocol is also used to evaluate healing of both interfacial damage and matrix cracking
using the resin-solvent healing chemistry.
Next, the thermal stability of microcapsules is studied in order to use a microencap-
sulated solvent-based healing approach in composite materials cured at high temperatures
(Chapter 5). The high temperatures common in composite processing techniques often com-
promise the integrity of capsule shell walls. Several methods for improving thermal stability
of three size scales of capsules were explored including: shell wall composition, modification
of the core solution, and addition of a poly(Dopamine) coating.
In Chapter 6, solvent-based healing is applied to a high Tg thermoplastic-toughened
epoxy, cured at 180◦C. After screening various thermoplastic/solvent pairs, the combination
of poly (bisphenol A-co-ephiclorohydrin) (PBAE)/ ethyl phenylacetate (EPA) was iden-
tified as the healing system with both the highest healing performance and the greatest
improvement in mechanical properties. The healing chemistry remained stable after room
temperature aging for up to 1 month.
A summary of current progress is given in Chapter 7 and suggestions for future work are
discussed.
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Chapter 2
Self-healing of Glass Fiber/ Epoxy
Interfaces∗
Fiber/matrix debonding in advanced composites has recently become a focus of self-healing
research [41, 44, 66]. Techniques for measuring interfacial bond strength, shown schemati-
cally in Figure 2.1, include fiber pull-out,[81–83], fiber fragmentation [84–88] and fiber push-
out [89–93]. The fiber pull-out test (Figure 2.1a) greatly simplifies assessment of healing
because the embedded bond length remains the same after debonding occurs.
P
leEpoxy Microbond
Glass Fiber
le
P
P
PP
(a) (b)
(c) (d)
Figure 2.1: Schematics of interfacial debonding tests. (a) Fiber pull-out from a microdroplet
deposited on a single fiber, (b) fiber pull-out with a semi-spherical microbond, (c) fiber
fragmentation, and (d) fiber push-out.
Several interfacial healing schemes have been reported in the literature. Peterson et al.
[66] developed a successful remendable approach to heal interfacial damage. Maleimide-
functionalized single glass fibers in a furan-functionalized epoxy were able to recover an
∗Significant portions of this chapter were published in Jones et al. Composites Science and Technology
(2013).
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average of 41% recovery after heat treatment. Sanada et al. [41] surrounded a single glass
fiber with 200 µm diameter dicyclopentadiene (DCPD) filled capsules and solid particles of
1st Generation Grubbs’ catalyst. Minimal recovery of IFSS (ca. 10%) was achieved for high
loadings of capsules (ca. 40 wt%). Blaiszik et al. [44] obtained significantly higher healing
efficiencies (ca. 44%) by reducing the size of the microcapsules by an order of magnitude
(ca. 1.5 µm)[9] and functionalizing both catalyst and microcapsules directly on the surface
of a glass fiber (Figure 2.2). A rectangular microbond specimen geometry was adopted
and both a control specimen without any capsules or catalyst (Figure 2.2a) and a self-
healing specimen with capsules functionalized onto the surface (Figure 2.2b) were tested.
Healing performance increased with increasing capsule coverage in contrast to three control
specimens which only show recovery of frictional forces inherent in single fiber microbond
testing (Figure 2.2c).
c
Figure 2.2: Optical micrographs of (a) a control specimen and (b) a self-healing specimen
functionalized with capsules (DCPD) and catalyst (1st Generation Grubbs’). (c) Effect
of capsule coverage on healing performance where SH denotes self-healing specimens, CI
represents a control with a plain glass fiber embedded in epoxy, CII is a control with catalyst
only and CIII represents specimens prepared with capsules only on the interface. These
results show both capsules and catalyst are required for high healing efficiencies [44].
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In this chapter, we adopt a single capsule, solvent-based healing chemistry to heal interfa-
cial damage using capsules less than 1 µm in diameter. The healing chemistry is an example
of latent functionality, originally developed for self-healing of bulk polymers by Caruso et al.
[27]. The proposed mechanism uses a solvent to (a) increase the molecular mobility of the
residual functionality in the matrix and (b) swell the matrix material in order to decrease
the crack separation. As the solvent diffuses through the undercured matrix, the local glass
transition temperature is lowered, which promotes further curing of epoxy. Additionally,
resin is co-encapsulated with the solvent to provide additional material for cross linking [94].
The rates of diffusion and evaporation of the solvent each play a role in the success of
this healing chemistry. Neuser and coworkers [29] examined the rate of diffusion of EPA into
EPON 828:DETA (the epoxy matrix used in this work) and found the solvent concentration
was constant up to a critical diffusion length (case II diffusion). After 24 h, the thickness of
the swelled region was 15 µm with a concentration of ca. 25% EPA. While this concentration
of EPA can cause a delay in the gel point (from 3.5-10 h) of neat epoxy, in a later study Neuser
and coworkers observed crack arrest in fatigue after as little as 2 h [30]. Additionally, Caruso
et al. observed healing after only 30 min using chlorobenzene, another high boiling point
solvent with high healing performance. After 12 h, the healing efficiency, using chlorobenzene
as the solvent, plateaued at ca. 80% [94].
While evaporation of EPA was not explored in either of the aforementioned works by
Neuser et al., prior studies on evaporation of solvents from polymers (e.g. during solvent
casting) show evaporation is initially rapid until reaching a lower limit controlled by diffusion
[95]. In the case of the resin-solvent healing chemistry, the initial rapid evaporation of the
solvent is likely addressed by incorporation of excess solvent healing agent. The fact that
the healing efficiency plateaus in prior studies, and also in the present work, suggests that
this minimum concentration requirement is met. After the healing event, evaporation of the
solvent from the matrix should proceed at a slower timescale than the initial diffusion due
to the additional cross linking that repaired the crack.
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2.1 Materials and Methods
A summary of the method used to demonstrate full recovery of IFSS using a single fiber
microbond technique is provided below. A more in-depth discussion of changes made for the
present work when compared to prior work by Blaiszik et al. [44] is available in Appendix A.
2.1.1 Microcapsule Method: Materials and Characterization
Two types of microcapsules containing EPON 862 (diglycidyl ether of bisphenol-F) dissolved
in ethyl phenylacetate (EPA) solvent were prepared by in situ polymerization of urea and
formaldehyde (UF) using a modified process of Blaiszik et al. [9], summarized in Table 2.1.
Modifications were made to reduce polydispersity and minimize excess surfactant. For both
capsule types, the resin-solvent solution was slowly added to a 30 mL aqueous solution of
approximately 1.25% ethylene maleic anhydride copolymer (ZeMac 400 EMA), urea, resor-
cinol and ammonium chloride and allowed to equilibrate for 10 min before sonication. For
Type 1 capsules, the resin-solvent ratio of the core was varied from 0 to 50 percent. For Type
2 capsules, hexadecane was co-dissolved in the resin-solvent core to increase hydrophobicity
and decrease Ostwald ripening [9]. A 3.2 mm tapered tip of a 750 W Ultrasonic Homog-
enizer (Cole-Parmer) was placed in the solution for 2 min at 40% intensity with a 0.2 sec
pulsing parameter under continuous agitation at 800 rpm. Formalin was then added to the
encapsulation. The temperature control bath was slowly heated to 55◦C and held constant
for 4 h. After the reaction was complete, the capsules were centrifuged and rinsed three
times to remove excess surfactant.
Microcapsule size distributions were obtained via SEM (FEI/Phillips XL30 ESEM-FEG).
All size distributions were determined from a minimum of 200 measurements from multiple
images. Thermal stability and overall capsule quality was assessed by thermogravimetric
analysis (TGA) in a nitrogen atmosphere at a heating rate of 10◦C/min (Mettler Toledo
TGA/DSC 1). Capsules were lyophilized for 3 days before thermal testing.
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Table 2.1: Parameters for resin-solvent filled capsule types.
Components Type 1 Type 2
Aqueous phase 15mL H2O, 15mL
2.5% EMA
15mL H2O, 15mL
2.5% EMA
Urea 0.45 g 0.45 g
NH4Cl 0.1 g 0.1 g
Resorcinol 0.045 g 0.045 g
Formalin 1.2 g 1.2 g
Core 5 mL resin-solvent 4.5 mL resin-solvent
Co-stabilizer None 2.5wt% Hexadecane
2.1.2 Interfacial Functionalization
E-glass fibers with a proprietary epoxy-compatible sizing were obtained from Owens Corning
(Type 158B-AA-675). The glass fibers had an ultimate tensile strength of 2.0 ± 0.15 GPa
and an average diameter of 14.5 ± 0.8 µm [44]. Self-healing (SH) functionalized fibers
were coated with resin-solvent microcapsules using a dip-coat technique. A single E-glass
fiber was isolated from the tow and dipped once in an aqueous suspension of resin-solvent
capsules of known concentration. The electrostatic properties of the glass fibers attracted
the capsules to the surface without any additional chemical bonding or adjustment of pH of
the solution. Dip time, speed of fiber removal from the dip bath, and agitation of the dip
bath were additionally examined, but the most critical factor in consistent capsule coating
was complete submergence in the dip bath itself. The capsule coverage, ξ, is defined as the
surface area of capsules on the surface of the fiber divided by the surface area of the fiber,
or
ξ ≈ Npir
2
cap
pidle
, (2.1)
where N is the number of capsules present on the surface of the fiber, rcap is the radius
of the capsule, d is the diameter of the fiber, and le is the embedded length of the fiber
in the microbond specimen. Capsule coverage, ξ, was measured by image analysis of SEM
micrographs. Representative SEM images of fibers with varying capsule coverage are shown
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in Figure 2.3. Single fibers were functionalized with several different types of capsules that
varied in both diameter and resin-solvent ratio (Table 2.2).
Figure 2.3: SEM micrographs of glass fibers (sample type SH1-97) with varying capsule
coverage (ξ).
2.1.3 Microbond Specimen Preparation
Microbond specimens consisted of a single glass fiber embedded in an epoxy droplet as
shown in Figure 2.4. This geometry was selected from a variety of interfacial bond strength
characterization tests primarily because the embedded bond length remains constant before
and after testing, which is ideal for calculation of healing performance. A micropipette
was used to apply a bead (180-230 µm in length) of epoxy to either plain (as-received)
or functionalized fibers. EPON 828 (diglycidyl ether of bisphenol-A) resin and EPIKURE
DETA (diethylenetriamine), an aerospace grade epoxy with high bond strength, was mixed
at 12 pph DETA to EPON 828, degassed and allowed to react at room temperature for 2 h
before being applied to the fibers. The specimens were cured at room temperature for 24 h
and then 24 h at 35◦C.
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Figure 2.4: a) Schematic of microbond test. b) Optical micrograph of a control and (c)
self-healing microbond specimen.
2.1.4 Microbond Test Method
After curing, optical images (Figure 2.4) were obtained before testing in order to measure
the embedded length (le) of each specimen. The samples were tested with a custom-built
load frame and imaged simultaneously through a zoom lens to observe interfacial debonding.
Samples were loaded in displacement control using a linear actuator (Physik Instrumente)
translating at a rate of 0.5 µm/s and controlled through LabVIEW (National Instruments,
v10.0). Load was measured with a 150 g load cell (Honeywell Sensotec). Samples were
loaded to the maximum force (Pmax) needed to cause full interfacial debond. After debond,
the force dropped quickly and then slowly increased to a frictional plateau value (Pfriction).
The sample was then removed from the load frame and allowed to heal for 24 h at room
temperature.
The IFSS (τ) was calculated from the peak applied force (Pmax), the fiber diameter (d),
and the embedded length (le),
τ =
Pmax
pidle
. (2.2)
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The healing efficiency (η) was defined as the ratio of the recovered interfacial shear
strength to the original value,
η =
τhealed
τvirgin
=
Pmax,healed
Pmax,virgin
. (2.3)
In some specimens, Nile Red dye (Sigma-Aldrich) was added to microcapsules (≈ 0.03 wt%
of resin-solvent core) with a resin-solvent ratio of 3:97 to visualize in situ healing agent deliv-
ery. Microbond specimens containing the dyed capsules were imaged both before and after
interfacial debond on a confocal microscope (Leica SP2).
2.2 Results and Discussion
2.2.1 Microcapsule Characterization
Representative SEM images of the two types of resin-solvent microcapsules prepared accord-
ing to Table 2.1 are shown in Figure 2.5 along with corresponding size distributions. Type
1 microcapsules ranged in size from 1.2-3.7 µm in average diameter depending on the ratio
of resin to solvent in the core as summarized in Table 2.2. The average diameter decreased
from 3.7 µm for the case of no resin (SH1-100) to approximately 1.2 µm for a resin-solvent
ratio of 30:70 (SH1-70). We attribute this decrease in capsule size to the extension of emul-
sion droplet lifetime provided by the increased viscosity of the resin compared to EPA. The
significant decrease in diameter (0.6 ± 0.3 µm) achieved for Type 2 microcapsules (SH2-70)
is due to the addition of hexadecane, an ultrahydrophobe, which provided further chemical
stabilization to the emulsion (Figure 2.5b).
Microcapsule quality was also evaluated by thermal stability testing. Representative
TGA traces, presented in Figure 2.6, show excellent stability with no significant mass loss
before reaching the boiling point of EPA (ca. 225◦C). The precipitous loss of mass at ca.
225◦C corresponds to the mass of EPA encapsulated. The second region of mass loss initi-
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Figure 2.5: Typical size distribution and corresponding SEM image for a) Type 1 capsules
with an average diameter of 2.1 ± 0.7 µm (used in SH1-97 samples) and b) Type 2 capsules
with an average diameter of 0.6 ± 0.3 µm (used in SH2-70 samples).
ating at ca. 350◦C is associated with the mass of encapsulated EPON 862 and hexadecane
(if present). The residual mass corresponds to shell wall material.
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Figure 2.6: Representative TGA traces of microcapsules.
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2.2.2 Recovery of Interfacial Shear Strength
Self-healing of the fiber/matrix interfacial bond was assessed by repeated testing of mi-
crobond specimens. A variety of samples were tested with different types of microcapsules
functionalized on the glass fibers. A summary of the different sample types, IFSS values,
and healing performances is provided in Table 2.2.
Table 2.2: Interfacial strengths and healing efficiencies for glass fiber/ epoxy microbond speci-
mens.
Sample Core Content Capsule Virgin IFSS Healing Capsule No. of
Type (862: EPA) Dia. (µm) (MPa) Efficiency, η Coverage, ξ Samples, n
SH1-100 0:100 3.7 ± 1.1 26 ± 1.9 0.72 ± 0.06 0.5 8
SH1-97 3:97 2.1 ± 0.7 33 ± 1.7 0.46 ± 0.07 0.3 14
29 ± 3.7 0.63 ± 0.08 0.4 8
28 ± 1.7 0.70 ± 0.06 0.5 13
23 ± 1.7 0.86 ± 0.07 0.7 16
SH1-90 10:90 1.7 ± 0.8 27 ± 1.5 0.66 ± 0.07 0.5 9
30 ± 1.6 0.58 ± 0.09 0.3 8
SH1-80 20:80 1.3 ± 0.5 25 ± 2.6 0.76 ± 0.09 0.5 8
27 ± 2.5 0.63 ± 0.10 0.3 16
SH1-70 30:70 1.2 ± 0.5 33 ± 3.1 0.53 ± 0.08 0.5 9
28 ± 3.0 0.71 ± 0.09 0.3 11
SH1-50 50:50 1.4 ± 0.6 32 ± 2.4 0.62 ± 0.05 0.5 4
31 ± 1.6 0.51 ± 0.08 0.3 9
SH2-70 30:70 0.6 ± 0.3 32 ± 3.0 0.34 ± 0.05 0.4 12
27 ± 3.1 0.50 ± 0.05 0.5 10
23 ± 1.3 0.60 ± 0.08 0.7 11
SH-DCPD1 - 1.6 ± 0.5 27 ± 4.3 0.29 ± 0.06 0.1 11
26 ± 2.1 0.36 ± 0.06 0.4 14
21 ± 2.5 0.44 ± 0.05 0.7 18
Control - - 32 ± 3.6 0.24 ± 0.04 - 9
1 The capsule coverages were adapted from Blaiszik et al. [44] for comparison to the present
work. Also, a different matrix was used in the prior work which resulted in lower virgin IFSS
values.
Results from Blaiszik et al. [44], which use a DCPD/ Grubbs’ 1st Generation catalyst
healing chemistry and a slightly different matrix of 40 pph EPIKURE 3274 to EPON 828,
are also included for comparison. A representative load-displacement curve is shown in
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Figure 2.7a for a self-healing specimen (SH1-97). The sample is loaded to 320 mN (Pmax),
before full interfacial debonding, and then quickly reaches the frictional plateau of 70 mN
(Pfriction). After 24 h, the sample is re-tested and full recovery of IFSS is achieved for
this particular resin-solvent ratio of 3:97. This healing chemistry resulted in the highest
healing efficiency of those considered in Table 2.2. Interestingly, Caruso et al. [27] also
found maximum healing at this ratio in bulk polymers. The control specimens, consisting
of a plain glass fiber embedded in the same epoxy matrix, only recovered the frictional force
(η = 0.24) 24 h after initial testing (Figure 2.7b).
b)a)
Figure 2.7: Representative load-displacement curves for microbond testing of (a) self-healing
(SH1-97) specimen with 100% recovery of IFSS, and (b) control specimen, which only re-
covers frictional force.
In select specimens, the healed region was visualized using confocal fluorescence mi-
croscopy. Initially, the capsules were intact with distinct shell walls (Figure 2.8a). After
loading, a large percentage of the capsules were ruptured and the healing agent was wicked
into the crack plane forming regions of healed interface (Figure 2.8b). The healed material
was not evenly distributed along the fiber/matrix interface, implying healing agent delivery
could be further optimized with the goal of reducing the required amount of capsules for
maximum healing performance.
20
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Figure 2.8: Confocal fluorescent microscope images of microbond specimens (SH1-97) and a
capsule coverage, ξ=0.5 (a) prior to testing and (b) after full debonding.
Effect of Capsule Coverage
Four different capsule coverages were investigated (ξ = 0.3, 0.4, 0.5, 0.7) for the resin-solvent
ratio of 3:97 (sample type SH1-97). The effect of capsule coverage on healing efficiency
is summarized in Figure 2.9 and compared to previous results for the DCPD/ Grubbs’
1st Generation catalyst healing chemistry [44]. Higher capsule coverages resulted in more
healing agent delivered to the crack plane and higher healing efficiencies for both healing
chemistries. Similar to prior studies [27], the resin-solvent healing chemistry produced higher
healing efficiencies than the DCPD/Grubbs’ healing chemistry. The increase in healing
performance is attributed to improved bonding of an epoxy-based healed film to both the
epoxy matrix and glass fiber reinforcement. Additionally, the sensitivity of the Grubbs’
catalyst to processing conditions limited healing performance unless additional protection
schemes were employed.
The effect of interfacial functionalization on healing performance and virgin IFSS is
reported in Table 2.2. At low concentrations, the addition of microcapsules led to modest
increases of the virgin IFSS. However, further increases in capsule coverage (ξ=0.5, η=0.7)
caused a small reduction in IFSS due to less available surface area for the matrix to bond
to the fiber. At the highest capsule coverage (ξ=0.7), there was a more significant loss of
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[3]
Figure 2.9: Healing efficiency as a function of capsule coverage for capsules containing 3:97
resin-solvent ratio (SH1-97) and SH-DCPD adapted from Blaiszik et al. [44].
IFSS, but healing performance was maximized. Interestingly, the IFSS values for submicron
Type 2 capsules (SH2-70, capsule diameter ca. 0.6 µm) were similar to those for the larger
capsules (SH1-97, capsule diameter ca. 2 µm), indicating the effect of the two microcapsule
sizes on IFSS is the same.
Effect of Resin-Solvent Ratio and Capsule Size
Microcapsules were prepared over a range of resin-solvent ratios as listed in Table 2.2. Mi-
crobond specimens functionalized with these capsules were tested and healing efficiency was
calculated as a function of the volume of resin (EPON 862) delivered to the crack plane
(Figure 2.10). The volume (V ) delivered was calculated from
V =
4
3
pircapξdleφ, (2.4)
where rcap is the radius of the capsule, ξ is the capsule coverage, d is the diameter of the
fiber, le is the embedded length of the fiber, and φ is the percentage of resin encapsulated.
22
Eqn. 2.4 assumes that all capsules rupture and as such represents a theoretical upper limit.
For samples made with Type 1 capsules, we found a critical volume of resin (ca. 200 µm3)
was necessary for high healing efficiencies. Healing efficiency was maximum at 300 µm3
using SH1-97 capsules with ξ = 0.7. Increasing the volume of resin delivered did not further
increase healing efficiency. A similar effect was noted by Caruso et al. [27] for bulk epoxy
in which it was hypothesized that an excess of resin in the crack plane leads to incomplete
cure by residual amines in the matrix.
Figure 2.10: The performance of Type 2 submicron capsules is highlighted in comparison to
Type 1 capsules.
For healing experiments with smaller Type 2 capsules, a resin-solvent ratio of 30:70 was
selected in order to increase the volume of resin delivered to the crack plane. Due to the
reduction in capsule diameter, and therefore healing agent delivered, a higher percentage
of encapsulated resin is necessary in order to reach the critical volume of resin indicated
in Figure 2.10. Microbond specimens functionalized with Type 2 capsules were tested and
the average healing efficiencies recorded. The results are plotted with the values obtained
from larger Type 1 capsules in Figure 2.10. A maximum of 83% healing efficiency was
obtained using 0.6 µm submicron capsules for select samples at a capsule coverage of ξ=0.7.
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In general for Type 2 capsules, a greater volume of EPON 862 is required to attain high
healing efficiencies (Figure 2.10). The observed decrease in performance, when compared to
the larger capsules, is likely due to residual hexadecane in the crack plane and a lower core
to shell ratio for similar capsule coverages.
2.3 Conclusions
Nearly full recovery of interfacial shear strength for a glass/epoxy composite was achieved
with a single capsule, resin-solvent self-healing chemistry. With increasing capsule coverage,
higher healing efficiencies were achieved with only a small decrease in the IFSS. The effect of
the resin-solvent ratio was also examined with respect to the volume of EPON 862 delivered.
A critical volume of EPON 862 resin (ca. 300 µm3) was required for maximum recovery of
IFSS. Above this critical volume, however, the healing efficiency did not increase further.
This critical volume of resin was used to prepare submicron capsules (0.6 µm diameter) using
a resin-solvent ratio of 30:70, in which a maximum of 83% recovery of IFSS was achieved.
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Chapter 3
Self-healing of Carbon Fiber/ Epoxy
Interfaces∗
In this chapter, we apply autonomous repair of interfaces to a single carbon fiber embedded
in an epoxy matrix. Self-healing of the carbon fiber/epoxy interface is challenging due to the
size scale of carbon fibers (ca. 5 µm in diameter) and the electrokinetic potential of carbon
fibers in comparison to glass fibers. Sized glass fibers possess a positive zeta potential, while
the electrical charge of sized carbon fibers is neutral or negative [96]. Although capsules have
a high affinity for the glass fiber surface [48], an additional binder is necessary to stabilize
capsules at the carbon fiber/ matrix interface. We examine two different binder techniques
and the effect of capsule concentration on recovery of IFSS.
3.1 Materials and Methods
3.1.1 Encapsulation of Healing Agents
Capsules containing a resin-solvent solution were prepared by in situ polymerization of urea-
formaldehyde (UF) as described in Chapter 2. The core solution contained a mixture of
2.5 wt% hexadecane, an ultrahydrophobe, and a 30:70 ratio by wt. of EPON 862 (diglycidyl
ether of bisphenol-F): ethyl phenyl acetate (EPA). This core solution was slowly added to
a 30 mL aqueous solution of approximately 1.25 wt% ethylene maleic anhydride copolymer
(ZeMac 400 EMA, Vertellus), 0.45 g of urea, 0.1 g of ammonium chloride, and 0.045 g of
resorcinol under mechanical agitation at 800 rpm. The mixture was allowed to equilibrate
∗Significant portions of this chapter were published in Jones et al. ACS Applied Materials and Interfaces
(2014).
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for 10 min before sonication. A 3.2 mm tapered tip of a 750 W Ultrasonic Homogenizer
(Cole-Parmer) was used at 40% intensity with a 0.2 s pulsing parameter for 1 min. Formalin
(1.2 g) was then added to the encapsulation and the temperature of the control bath was
increased to 55◦C at 1◦C/min and held for 4 h. Capsules were centrifuged to remove excess
surfactant and used in an aqueous solution to size carbon fibers. EPON 862 was purchased
from Miller-Stephenson. EPA, urea, ammonium chloride, and resorcinol were purchased
from Sigma Aldrich.
3.1.2 Fiber Functionalization
Carbon fibers with a proprietary epoxy-compatible sizing were obtained from Hexcel (IM7-
G). Single carbon fibers were isolated from a fiber tow and the fiber surface was decorated
with capsules using a dip coat technique. In contrast to glass fibers [44, 48], a binder was
required to keep capsules at the carbon/fiber epoxy interface and to achieve repeatable
healing performance. Two different methods, summarized in Figure 3.1, were developed to
apply the binder to the carbon fiber surface. Additional details on selection of binders are
available in Appendix A.2. In the first method, Binder Method I, a stoichiometric mixture
of Epodil 749 (Momentive), an epoxy diluent, and diethyltriamine (DETA, Sigma Aldrich)
was prepared. The binder was allowed to precure before single carbon fibers were dipped
in the mixture. Coated single carbon fibers were then immediately dipped into an aqueous
suspension of capsules at a known concentration (varied from 5-15 wt%).
In Binder Method II, an aqueous suspension of phenoxy (HP302, Michelman, Inc.) was
combined with an aqueous capsule solution of known concentration. The binder concentra-
tion was varied from 1-4 wt% of the capsule solution, with 1 wt% yielding the most consistent
coverage. The wt% total solids was varied from 5-25 wt% with 15 wt% yielding the highest
coverages while minimizing agglomerations of capsules. The pH of the solution was critical
for consistent, even coverage and was adjusted to 3.6 using solutions of HCl and NaOH.
For both methods, the capsule coverage, ξ, is defined as the surface area of capsules on
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Binder Method I Binder Method II
Isolate single IM7 carbon 
fiber from tow
Precure 100:16 
Epodil 749:DETA 
binder 
Add 1 wt% HP302 
to an aq. solution of 
15wt% capsules 
and adjust pH 
Dip coat carbon 
fibers with 
precured binder
Dip coat carbon 
fibers with binder 
in aq. solution of 
15wt% capsules 
Dry functionalized 
fibers for 2.5 h
Apply microdroplet of 
epoxy with micropipette
Dip coat carbon 
fibers with aq. 
suspension of 
binder and capsules
Dry functionalized 
fibers for 15 min
Figure 3.1: Methods for applying binder and capsules to the carbon fiber surface.
the surface of the fiber divided by the surface area of the fiber, or
ξ ≈ Npir
2
cap
pidle
, (3.1)
where N is the number of capsules present on the surface of the fiber, rcap is the radius of
the capsule, d is the diameter of the fiber, and le is the embedded length of the fiber in the
microbond specimen (as in Chapter 2). Capsule coverage, ξ, is measured by image analysis
of SEM micrographs.
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3.1.3 Microbond Specimen Preparation
Microbond specimens consisted of a single carbon fiber embedded in an epoxy droplet as
shown in Figure 3.2. For Binder Method I, capsule-functionalized fibers were allowed to dry
for 2.5 h before application of the epoxy microbond to ensure the degree of cure of the binder
consistent. For Binder Method II, only 15 minutes was required to remove excess water since
functionalization was not dependent on a precure time. Three types of control specimens
were prepared in a similar fashion. The first control (C0) consisted of an as-received carbon
fiber (no binder, no capsules) embedded in an epoxy droplet. For the other two controls (CI
and CII), carbon fibers were prepared with binder alone but no capsules.
A micropipette was used to apply a bead of epoxy (80-130 µm in length) to either as-
received or capsule-functionalized fibers. EPON 828 (diglycidyl ether of bisphenol-A) resin
and DETA (diethylenetriamine), an aerospace grade epoxy with high bond strength, was
mixed at 12 pph DETA to EPON 828, degassed and allowed to react at room temperature
for 1 h before being applied to the fibers. The specimens were cured at room temperature
for 24 h and then at 35◦C for 24 h. This cure cycle resulted in a slightly undercured (ca.
80%) matrix with residual functionality.
3.1.4 Microbond Test Method
After curing, the embedded fiber length (le) of each specimen was measured optically (Fig-
ure 3.2). The samples were tested with a custom-built load frame as described in Chapter 2
and imaged simultaneously through a zoom lens (Navitar) to observe interfacial debonding.
Samples were loaded in displacement control using a linear actuator (Physik Instrumente)
translating at a rate of 0.5 µm/s and controlled through LabVIEW (National Instruments,
v10.0). Force was measured with a 150 g load cell (Honeywell Sensotec). Samples were
tested to the maximum force (Pmax) needed to cause full interfacial debond. After debond,
the force dropped quickly and then slowly increased to a frictional plateau value (Pfriction).
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The sample was then removed from the load frame, allowed to heal for 24 h at room tem-
perature, and then re-tested following the same protocol.
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Figure 3.2: Single fiber microbond specimens. (a) Schematic of a microbond test configu-
ration and (b) optical micrograph of a carbon fiber/epoxy microbond. (c) SEM of a plain
carbon fiber surface used in a control specimen, and (d) SEM of a carbon fiber for a self-
healing specimen.
The IFSS (τ) was calculated from the peak applied force (Pmax), the fiber diameter (d),
and the embedded length (le),
τ =
Pmax
pidle
. (3.2)
The healing efficiency (η) was defined as the ratio of the recovered interfacial shear strength
to the original value,
η =
τhealed
τvirgin
=
Pmax,healed
Pmax,virgin
. (3.3)
3.2 Results and Discussion
3.2.1 Capsule Coverage
The capsule coverage, ξ, for Binder Method I, is shown in Figure 3.3 as a function of the
binder precure time for a capsule concentration of 15 wt% in deionized water. The degree
of cure of the binder before submerging in the aqueous capsule suspension was critical to
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achieve consistent coverage. Immediately after mixing the amine and diluent of the binder
material together (time, t=0), the coverage was low but still higher then the case where no
binder was used (dashed line). After 30 min of precure time the coverage increased slightly
and stabilized for the next 30 min (t=60 min precure time). At a binder precure time
of 80 min, large agglomerations of capsules began to form and coat the single fiber. The
magnitude of the coverage varied with capsule concentration and ambient curing conditions,
but the overall trend remained the same. Capsule coverage was quantified for each batch of
samples.
No binder 
Consistent 
Coverage 
Agglomerations
10 µm
No binder
Time=0 min
Time=30 min
Time=80 min
(a) (b)
Figure 3.3: Capsule coverage for Binder Method I. (a) SEM images of carbon fibers prepared
with Binder Method I for different binder precure time. b) Capsule coverage, ξ, as a function
of increasing binder cure time. The dashed line indicates the lower coverage resulting from
carbon fibers functionalized without a binder.
Due to the inherent variation in Binder Method I and issues with cross-contamination
in the second dip bath, a second binder protocol was explored. For Binder Method II, an
aqueous suspension of binder (HP302) was combined with capsules to produce a single step
water-based self-healing sizing. For this method, capsule coverage was strongly dependent
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on pH of the solution (Figure 3.4). At low pH (ca. 3.3), capsule coverage along the fiber
surface was not uniform with either agglomerations of capsules or no coverage at all. As
the pH increased, the capsule coverage became more consistent until higher pH values (ca.
3.9). For the pH of 3.9, the capsule coverage was negligible. The pH of the capsule solution
controlled the charge on the capsule surface, which affected the affinity of the capsules to
the fiber surface.
10 µm
pH=3.3
pH=3.5
pH=3.7
pH=3.9
(a) (b)
Optimal
 Coverage 
Figure 3.4: Capsule coverage for Binder Method II. (a) SEM micrographs of carbon fibers
prepared with Binder Method II for different solution pH. (b) Capsule coverage for increasing
pH of the sizing solution.
3.2.2 Recovery of IFSS
Self-healing of the fiber/matrix interfacial bond was assessed by testing of microbond speci-
mens. A summary of sample designations, healing performance, and IFSS values is provided
in Table 3.1. Three different controls were tested to evaluate first the baseline bond strength
of a carbon fiber embedded in epoxy (C0), as well as the effect of each of the binders alone
on the IFSS (CI and CII). Self-healing specimens were prepared without any binder (SH),
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with Binder Method I at multiple coverages (SHI) and with Binder Method II at a cap-
sule coverage of ξ=0.6 (SHII). Results from Chapter 2, for glass fibers functionalized with
similar capsules, but no binder, and embedded in the same epoxy droplet are included for
comparison.
Table 3.1: Interfacial strengths and healing efficiencies for different specimen types
Sample Virgin IFSS Healing Capsule No. of
Type (MPa) Efficiency, η Coverage, ξ Samples,n
C0: As Received Carbon Fiber 44.0 ± 6.6 0.21 ± 0.05 - 19
CI: Binder 1 Only 48.7 ±8.1 0.17 ± 0.04 - 11
CII: Binder 2 Only 47.9 ± 5.7 0.32 ± 0.08 - 7
SH: No binder 35.2± 5.2 0.25 ± 0.05 0.22 22
SHI :Binder Method I 41.6 ± 2.8 0.37 ± 0.02 0.34 8
32.3 ± 2.5 0.48 ± 0.05 0.56 18
25.7 ± 1.9 0.57 ± 0.05 0.63 21
SHII:Binder Method II 26.9 ± 5.4 0.83 ± 0.17 0.61 8
SH-Glass1 32 ± 3.0 0.34 ± 0.05 0.4 12
27 ± 3.1 0.50 ± 0.05 0.5 10
23 ± 1.3 0.60 ± 0.08 0.7 11
1 Results from Chapter 2 with the same capsule size and core content are shown in
comparison to current work. The difference in IFSS is due to superior bonding
between the carbon fibers and epoxy microdroplet when compared to glass fibers.
A representative load-displacement curve is shown in Figure 3.5a for a self-healing speci-
men (Binder Method I) with a high capsule coverage (ca. ξ=0.6). The sample was loaded to
50 mN (Pmax), at which point full interfacial debonding occurred. The load then dropped
and quickly reached a frictional plateau of 15 mN (Pfriction). Ruptured capsules released
the resin-solvent healing agent into the crack plane. The solvent swelled the matrix, pulling
residual functionality to the crack plane that reacted with the co-encapsulated resin, and
formed a healed film. After 24 h, the sample was re-tested and ca. 75% recovery of IFSS
was achieved for select samples. Since the amount of solvent released is small, we believe
the swelling is highly localized and with time the solvent evaporates leaving little residual
effect on the matrix properties. Both Caruso [27] and Jones [48] achieved full recovery of
mechanical properties suggesting no degradation of the matrix material from the solvent.
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(a) (b)
Figure 3.5: Representative load-displacement curves for microbond testing of (a) self-healing
(SHI) specimens prepared with Binder Method I demonstrating η=75% recovery of IFSS and
(b) a control specimen consisting of a plain carbon fiber (C0) embedded in epoxy, which only
recovers frictional force.
Control specimens (C0), consisting of an as-recieved carbon fiber embedded in the same
epoxy matrix, only recovered the frictional force (η = 0.21) 24 h after initial testing (Fig-
ure 3.5b). As summarized in Table 3.1, control specimens, CI and CII, with binder but no
capsules also only recovered the frictional force. In both cases though, the addition of the
binder improved the interface strength. In prior work with glass fibers, two additional con-
trols were explored: microencapsulated DCPD monomer and pure EPA. Although DCPD
monomer is not a solvent, it has potential to swell the epoxy similar to EPA, but with-
out catalyst, has no healing ability. Blaiszik et al. [44] reports that healing efficiency of
specimens prepared with DCPD capsule functionalized fibers is within experimental error of
specimens prepared with plain as-received glass fibers (no healing effect). Jones et al. [48]
shows that healing efficiency for specimens prepared with EPA alone is well above (η=0.72)
the frictional recovery of plain glass fibers (η=0.24).
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3.2.3 Effect of Capsule Coverage
Three different capsule coverages were investigated (ξ = 0.34,0.56,0.63) for Binder Method I.
The effect of capsule coverage on healing efficiency is summarized in Figure 3.6 and compared
to previous results for similar glass fiber specimens [48]. Capsule coverage was quantified
prior to application of the epoxy microdroplet and healing performance was used to evaluate
the ability of the binder to effectively adhere capsules to the interface. Higher capsule cover-
ages result in more healing agent delivered to the crack plane and higher healing efficiencies.
The healing performance of Binder Method I is remarkably similar to the results for glass
fiber specimens prepared with submicron (ca. 0.6 µm in diameter) capsules, suggesting that
the healing chemistry is effective for multiple fiber/ epoxy systems. Binder Method II pro-
duced even higher healing performance when compared to Binder Method I and glass fiber
specimens prepared with similar microcapsules (0.6 µm in diameter). We hypothesize the
improvement in healing efficiency from Binder Method I to Binder Method II is likely related
to high capsule coverage that remains at the interface after application of the microdroplet
of epoxy. For comparison, glass fiber microbond specimens prepared with larger microcap-
sules (ca. 2 µm in diameter) are also included and represent the highest interfacial healing
performance obtained with this chemistry [48].
The effect of capsule coverage on virgin IFSS is also reported in Table 3.1. At low
concentrations (ξ=0.34), the addition of capsules minimally affected the virgin IFSS. The
average IFSS was below the virgin IFSS of an as-recieved carbon fiber/ epoxy microbond
(C0), but within the experimental error of this control specimen. This result differs from
our previous work with glass fiber/ epoxy microbonds where a low capsule coverage led to a
modest increase in virgin IFSS [48]. Further increases in capsule coverage (ξ=0.56) caused
a reduction in IFSS due to less available surface area for the matrix to bond to the fiber.
At the highest capsule coverage (ξ=0.63), there was a more significant loss of IFSS, but
healing performance was maximized. This trade off between high healing performance and
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Figure 3.6: Healing efficiency as a function of capsule coverage for carbon fiber specimens
prepared with Binder Method I, Binder Method II, and results for glass fiber microbond
specimens from Chapter 2. Error bars are 95% Confidence Interval.
high virgin IFSS was observed for both carbon and glass fiber/epoxy microbonds. Virgin
IFSS of self-healing carbon fiber/epoxy microbonds will likely be improved with a different
binder or a more uniform method of applying the capsules to the fiber surface.
3.2.4 Effect of Binder Method
Healing performance for the different binder methods is compared in Figure 3.7. Carbon
fiber/epoxy microbond specimens prepared without a binder had significantly lower cap-
sule coverage, and therefore had reduced healing performance. The addition of the binder
increased the capsule coverage and also aided in keeping capsules adhered to the fiber dur-
ing microbond application. Maximum healing performance increased to 57%, for Binder
Method I, while for Binder Method II, average healing efficiency further increased to ca.
80%. We hypothesize this is due to the lack of cross contamination between the two dip
bathes used in Binder Method I, which impeded the consistency of coverage. We anticipate
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further increases in healing efficiency may result from adjusting the ratio of solvent to resin
encapsulated and the improving the consistency of capsule coverage.
Figure 3.7: Comparison of Binder Method I (SHI) and Binder Method II (SHII) at the
same capsule coverage (ξ ≈ 0.6) and samples prepared without binder (SH, ξ = 0.22). The
capsule coverage for samples prepared without binder is significantly lower than for samples
prepared with a binder technique, which leads to a reduced healing performance for samples
without binder. Error bars are 95% Confidence Interval.
3.3 Conclusions
Autonomous repair of a high performance carbon fiber/ epoxy interface was achieved with a
maximum of 91% recovery. Healing efficiencies increased with higher capsule coverage, but
the virgin IFSS decreased due to reduced surface area for bonding. The application of binder
was critical for stabilizing capsules at the interface. Healing results using Binder Method I
and carbon fibers with an commercial epoxy-based sizing (IM7-G) were very similar to the
healing performance of a glass fiber with an aminopropylsilane (APS)-based sizing suggesting
that the resin-solvent healing chemistry can be applied over a wide range of fiber/matrix
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interfaces. Healing performance was maximized with Binder Method II due to the high
coverage of capsules that remains on the fiber interface during specimen manufacture. Future
work will be aimed at optimization of the coating methods for compatibility with composite
pre-pregging techniques.
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Chapter 4
Self-healing of Matrix Cracking and
Fiber Debonding in a Model
Composite
The previous two chapters focused on self-healing of the most basic model composite: a
single fiber embedded in a microdroplet of epoxy. Here, we add a level of complexity to
a model composite specimen by incorporating discrete fiber tows into an epoxy matrix.
Surprisingly, very few examples of tow-level tests are present in literature [97–101]. Zhao
and Botsis [97] introduced a model composite specimen consisting of a compact tension
(CT) specimen with uniformly spaced tows to investigate cohesive zone properties under
fracture and fatigue loading. By varying the placement of fiber tows, they were able to
achieve stable fracture, but with catastrophic failure. Ni et al. [100] developed a double
cleavage drilled compression (DCDC) specimen with a layer of carbon fiber tows aligned in
the same orientation as the crack. The thickness of the fiber layer influenced fiber bridging
and crack propagation. Bechel and Tandon [98] developed the cruciform test, which did not
incorporate fiber tows, but did examine the effect of an array of single fibers on interfacial
debonding in an epoxy specimen. To date, no tow-level characterization of self-healing has
appeared in the literature.
In this chapter, a protocol was designed with two goals in mind: (1) achieve solvent heal-
ing in a model composite with a low fiber volume fraction and (2) determine the relationship
between fiber tow failure and interfacial debonding in order to predict the propagation of
fracture in a composite computationally. The efforts towards the first goal are discussed
in the following chapter while supporting information towards the second goal is given in
Appendix B. The fracture behavior of a CT specimen with embedded tows is analyzed
first. SEM images show crack deflection and river markings in specimens with embedded
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fiber tows. The protocol developed is then used to evaluate healing with the resin-solvent
healing chemistry discussed in Chapters 2 and 3. Microcapsules are incorporated into the
matrix material and along the interface of the fiber tows in order to evaluate the effect of
microcapsules on fracture and healing performance.
4.1 Materials and Methods
4.1.1 Microencapsulation
Capsules were prepared using a double shell wall technique previously described by Caruso
et al. [94] and discussed later in Chapter 5. In this technique, polyurethane prepolymer
(Desmodur L75) undergoes a rapid interfacial polymerization forming the inner shell wall
which is followed by an in situ polymerization of urea and formaldehyde.
Two size scales of capsules were prepared. Large capsules (ca. 150 µm in diameter)
were fabricated for incorporation into the epoxy matrix. An aqueous solution of surfactant
(EMA) and shell wall formers (urea, ammonium chloride, and resorcinol) was prepared and
the pH was adjusted to 3.5 by dropwise addition of sodium hydroxide. The core material
was comprised of 3:97 EPON 862: ethyl phenyl acetate (EPA) and 0.05 g of Desmodur L75
per mL of core solution. The core solution was then slowly added to the aqueous solution
and allowed to emulsify for 20 minutes at 400 rpm. Formalin was added to the encapsulation
after 20 min and the temperature of the control bath was slowly ramped to 55◦C at 1◦C/min
for 4 h. After the reaction was complete, the microcapsules were dried on a vacuum assisted
filter and sieved to be between 75 and 250 µm in diameter.
Small capsules (ca. 2 µm in diameter) were prepared following a similar procedure
(outlined in detail in Chapter 5). Again, a core solution of 3:97 EPON 862:EPA was prepared,
but with 0.15 g of Desmodur L75 per mL of core solution and Nile Red fluorescent dye. The
added PU and Nile Red dye were required for the fiber functionalization process discussed
in the following section. The core solution was emulsified in an aqueous solution of shell
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wall formers and surfactant and then homogenized to reduce the capsule size. Formalin
was added after 10 min and temperature of the control bath was slowly ramped to 55◦C
at 1◦C/min for 4 h. After the reaction was complete, the capsules were lyophilized and
redistributed in DI H2O at a given concentration.
4.1.2 Fiber Functionalization
The fiber tows were functionalized with capsules using a technique developed by Kim et al.
[102]. Fiber tows were submerged in a sizing bath under sonication in order to promote
penetration of the microcapsules into the fiber tow. The sizing bath was part of an in-house
prepregging line designed to fabricate self-healing prepreg. The wt % capsules in the aqueous
sizing solution was 7 wt %. This led to a 6% (by volume) microcapsule concentration on the
fiber tows.
4.1.3 CT Specimen with Embedded Fiber Tows
Specimens were fabricated by aligning tows on an alignment fixture, shown in Figure 4.1.
Technical drawings of all parts in the fixture design are given in Appendix C.
Figure 4.1: Fixture used to align fibers for a model composite specimen. The mold depicted
here is a compact tension specimen mold.
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Figure 4.2: CT specimen geometry with embedded fiber tows. Fibers are perpendicular to
direction of crack propagation (denoted by the x-axis in red). Fiber tow spacing/ count was
varied. For neat epoxy or samples prepared with 1 fiber tow, a crack stop was placed 20 mm
from the end of the groove.
The compact tension (CT) specimen geometry was used for the model composite test.
Fiber tows were placed perpendicular to the crack plane with the first tow placed 5 mm
from the beginning of the groove (Figure 4.2). The specimen dimensions were selected based
on ASTM 5045, with a/W ca. 0.5. Once fiber tows were aligned the mold was clamped
to hold the tows in place. The epoxy, EPON 828: DETA (100: 12), was mixed, degassed,
and poured into the molds. Specimens were cured for 24 h at room temperature and 24 h
at 35◦C. A crack stop was added to select specimens in order to ensure the change in crack
length was constant between virgin and healed cases. All specimens were precracked before
testing by tapping a razor into the groove. Specimens were tested at 5 µm/sec in Mode I
tension until the crack arrested at a fiber tow or the crack stop.
To evaluate healing performance, specimens were unloaded after virgin testing and healed
for 24 h at room temperature. Reference tests (no capsules) were injected with solution of
3:97 EPON 862: EPA and Nile Red dye. The dye increased the contrast and improved the
visibility of crack propagation during the healing test. A new precrack was added before all
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healing tests to prevent crack tip blunting. Healing efficiency, η′′, was defined as the ratio
of normalized energy in the healed case divided by the normalized energy in the virgin case
(Equation 4.1). The area between the load-displacement data and the unloading data was
defined as the energy, U, to fracture both matrix and fiber tows. The energy was normalized
by the change in crack area: B∆a, where B is the specimen thickness and a is the crack
length in the epoxy matrix.
η′′ =
Uhealed/B∆ahealed
Uvirgin/B∆avirgin
(4.1)
4.2 Results and Discussion
4.2.1 Fracture Behavior of a Model Composite
Fracture behavior was studied for three specimen types: neat epoxy, epoxy with one em-
bedded tow, and epoxy with five embedded tows. Some initial tests were conducted with
in a tapered double cantilever beam (TDCB) specimen geometry, a fracture specimen com-
monly used in self-healing research due to the crack length independence. Unfortunately,
the tapered arms often broke during testing. Also, the central groove used to guide the crack
was problematic for imaging of fiber debonding. Thus, a compact tension (CT) specimen
geometry was adopted. Catastrophic failure, observed in the work by Zhao and Botsis [97],
was avoided by using a single row of fibers (instead of 3 rows) and a low fiber count in the
fiber tow (ca. 200 fibers per tow).
Representative load-displacement curves and optical images as the crack progresses for
all three specimen types are shown in Figure 4.3. For neat epoxy (Figure 4.3a), the crack
rapidly advanced to the crack stop and a singular peak in the load-displacement response
occurred. The location of the crack stop did not significantly impact the fracture response
in neat specimens, but specimens with a crack stop at 25 mm tended to break in half even
with the crack stop. Therefore, crack stop location of 20 mm (from the end of the groove)
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was selected to maintain both specimen integrity and a similar matrix crack length in all
specimens types (including the specimens with five fiber tows).
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Figure 4.3: Representative load-displacement curves (left) for (a) a neat epoxy compact
tension specimen, (b) a compact tension specimen with 1 embedded glass fiber tow (placed
5 mm from the groove) and (c) a compact tension specimen with five embedded tows (5 mm
apart each). Optical images of the corresponding crack progression and fiber tow debonding
are shown on the right. Arrows denote the location of the fibers.
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When a single fiber tow was embedded into the specimen (Figure 4.3b), the crack similarly
advanced to the crack stop in one step. During this event, the fiber tow also debonded
(seen as a dark region on the fiber surface). A second peak was observed, during which no
additional debonding occurred. We attributed this second peak to fiber fracture.
In the case of five fiber tows, multiple peaks were observed, indicative of the fiber tows
slowing crack growth. When the first peak occurred (Figure 4.3c, ¬), the crack progressed
from the precrack to the second tow and the first tow was partially fractured. Some addi-
tional debonding occurred in the first tow until it completely fractured at the second peak
(Figure 4.3c, ­). Also when the second peak occurred, the crack progressed to the fourth
tow, which caused fracture of the second tow (in addition to the remaining fracture of the first
tow) and debonding in the third and fourth tows. The final peak in the load-displacement
curve (Figure 4.3c, ®) occurred when the third tow fractured.
The average peak load and the average total energy absorbed during the fracture event (in
J/m2) increased gradually with the addition of fiber tows (Table 4.1). However, the length
of the debonding region along the fiber tows was similar for both the singular and multi-tow
specimens. Since the number of fibers in each tow was the same, each tow was capable
of withstanding the same load before fracture, and thus a similar amount of debonding
occurred. As discussed in Appendix B, the amount of debonding was altered when the local
fiber volume fraction changed; i.e when the spacing of the individual fibers inside each tow
was reduced. For all tests here, the local fiber volume fraction was constant.
Table 4.1: Summary of results for compact tension specimens with and without embedded
fiber tows
Sample Peak Energy Released (Virgin)b Energy Released (Healed)b Healing
Type Loada(N) (Uvirgin, J/m
2) (Uhealed, J/m
2) Efficiency (η′′)
Neat 69 ± 5.6 153 ± 41 181 ± 31 1.20 ± 0.4
1 tow 72 ± 8.1 168 ± 31 134 ± 26 0.83 ± 0.2
5 tows 80 ± 1.6 197 ± 30 95 ± 9.1 0.50 ± 0.1
a Peak load during the first fracture event
b Calculated as area under the curve normalized by the change in crack length in the epoxy
matrix
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The fracture surfaces were also examined using SEM. Neat epoxy (Figure 4.4a-b) exhib-
ited either a blank featureless surface or river markings [6, 103]. Chudnovsky and coworkers
attributed these river markings to inhomogenenities at the submicron level in epoxies. The
addition of a single fiber tow led to a significant amount of out of plane crack deflection
(Figure 4.4c-d) . The fibers debonded from the matrix and and often fractured in multi-
ple locations. In contrast, the specimens with five embedded fiber tows exhibited less out
of plane deflection and damage (Figure 4.4e-f). The additional fiber tows carried load as
the crack progressed, allowing the crack to more slowly advance through the material in a
controlled fashion.
200 µm
200 µm
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20 µm
20 µm
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Figure 4.4: SEM images of the fracture surface morphology for a neat epoxy specimen (a-b),
a specimen with a single embedded glass fiber tow (c-d) and a specimen with five fiber tows
(e-f).
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4.2.2 Self-healing in a Model Composite
Solvent Injection (Reference Test)
All three types of specimens were injected with a resin-solvent ratio of 3:97 EPON 862: EPA
and allowed to heal for 24 h at room temperature. The results are tabulated in Table 4.1
and representative load-displacement curves with corresponding SEM images are shown in
Figure 4.6. First, neat epoxy specimens fully recovered the energy lost during the fracture
event, and in some cases outperformed the virgin cases ( Figure 4.6a). In most of the cases
where the healed test outperformed the virgin test, the crack deflected out of the virgin
damage into undamaged material (Figure 4.5).
Virgin Crack
Crack Devation 
(after healing)
5 mm
Figure 4.5: Optical image of crack deviation during the healing event.
The resin-solvent ratio of 3:97 with a DGEBF resin (EPON 862) is just as effective as the
healing agents used in the work by Caruso et al. [27] ( 13 wt % EPON 828 in EPA). The
corresponding fracture surface exhibited smooth regions of healing agent deposition and
thinner regions where the healing agent barely coated the river marks.
Specimens with a single embedded fiber tow achieved an average of 83% recovery with full
recovery in several cases. In contrast to the virgin fracture surfaces shown in Figure 4.4c-d,
the healed fracture surfaces showed build-up of healing agent around the fiber tow (Fig-
ure 4.6b). Also, large gaps were present in the fracture surface, which were attributed to
removal of a plug of fiber-filled polymer (confirmed by SEM of the opposing fracture sur-
face). The last specimen type (with five embedded fiber tows) achieved only 50% recovery
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due to the the increase in energy lost during fiber fracture and the larger crack separations
(Figure 4.6c). At the crack opening, the crack separation was ca. 70 µm, which is signifi-
cantly larger than the 5-8 µm crack separations observed by Caruso in neat epoxy [27]. In
a study by Neuser et al., healing efficiency was significantly reduced for crack separations
greater than 30 µm [29]. The fracture surface was similar to specimens with only one tow
in that the fiber tows and healed polymer seemed to be removed as one large bulk during
the healing event.
Autonomous Healing (Capsules)
Microcapsules were incorporated (1) on the fiber interface on a single fiber tow embedded
in compact tension specimen and (2) throughout a neat epoxy specimen. Figure 4.7 shows
a representative load-displacement curve and optical images of a specimen (1 tow) with
capsules on the fiber interface. Despite the high loading of capsules (in order to maximize
healing potential), the average peak load during the first fracture event was almost identical
to specimens with no capsules. Also, out of plane matrix cracking occurred around the fiber
tow (observed as a dark halo around the tow optically or as a raised surface in SEM images).
However, in contrast to reference specimens, the fiber debonding continued during the second
fracture event. No measurable healing occurred, which was attributed to insufficient healing
agent to fill the crack plane.
A second set of samples was conducted with large (ca. 150 µm in diameter) capsules
throughout the matrix material. A representative load-displacement curve and correspond-
ing image are given in Figure 4.8 for a specimen with 10 wt % microcapsules. The crack
propagated in a controlled fashion to the crack stop, even though the specimen was a con-
stant thickness (no central guiding groove). A 15% increase in the average peak load was
observed due to microcapsule toughening [4].
For healing tests, attempts were made to precrack the specimens (post virgin testing but
before the healing tests), but the crack ran all the way to the crack stop. Thus, a few tests
47
100 µm
100 µm
a
b
c
Healed Film
Healed Film
100 µm
Healed Film
Figure 4.6: Representative load-displacement curves and SEM images of the healed fracture
surface morphology for (a) a neat epoxy specimen, (b) a specimen with a singular embedded
glass fiber tow and (c) a specimen with five fiber tows (after injection with 3:97 EPON 862
resin: EPA solvent). False color (purple) identifies healed film.
were conducted without precracking the specimen before the healing event. Examination
of the fracture surface suggested that minimal deposition of healing agents occurred in the
virgin precrack region, but more tests should be conducted to ensure omission of a precrack
prior to the healing test is valid. Additionally, a fatigue protocol could be developed (instead
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Figure 4.7: Self-healing response of a specimen with capsules on a singular fiber tow. (a)
Load-displacement response showing no healing. The load carried by the red curve is from
the unfractured area behind the crack stop. (b) Optical images during the test for the two
fracture events, showing an increase in debonding during the second fracture event.
5 mm
ba
Figure 4.8: Self-healing response of a neat specimen with 10 wt % microcapsules. (a) Load-
displacement curve showing high healing efficiency and (b) optical image of crack progression
to the crack stop. A thinner region (or groove) was not required for a straight crack path.
of manual precracking) in order to obtain more control of the precrack propagation.
Both of these sample sets suggest that the protocol could be used to demonstrate in situ
healing. Future work would investigate the effect of combining microcapsules in the matrix
and at the interface. Also, the ability of large capsules alone to heal both interfacial damage
and matrix cracking should be studied.
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4.3 Conclusions
A protocol was developed to examine how the addition of interfacial debonding to matrix
fracture affected healing performance. A compact tension specimen was adopted with em-
bedded glass fiber tows and the effect of the tows on fracture behavior was studied. Neat
epoxy specimens achieved full recovery after injection with a 3:97 resin:solvent solution of
EPON 862: EPA. The addition of a fiber tow reduced the healing performance to an average
of 83%, though full recovery was observed in select samples. When the amount of fiber tows
was increased, healing performance was reduced to ca. 50%. Microcapsules incorporated
at the fiber tow alone provided insufficient healing agent to heal both interfacial debonding
and matrix cracking. Use of microcapsules throughout the compact tension specimen was
much more promising in terms of healing potential, but a protocol should be developed for
controlled precracking before the healing test.
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Chapter 5
Capsule Thermal Stability
The encapsulated healing systems in the previous chapters were developed for low tem-
perature cured epoxy systems. In this chapter, methods to improve microcapsule thermal
stability, during target high temperature cure cycles, were explored. Prior literature has
used a variety of techniques to improve the thermal stability of microcapsules including:
careful selection of the core materials [104], multi-shell walls [94], silica or particulate pro-
tection [105], control of the degree of shell wall cross-linking, and choosing different ratios
of monomers used in encapsulation [106].
Double shell wall capsules developed by Caruso et al. [94] were adopted for this study
due to their superior thermal stability when compared to urea-formaldehyde (UF) single
shell-walled capsules. Several size scales of capsules were prepared and the thermal stability
was measured using thermogravimetric analysis (TGA). First, the effect on thermal stability
of different ratios of PU to UF for three different capsule sizes was explored. Though large
capsules, ca. 150 µm in diameter, were thermally stable at a high temperature of 180◦C
for 1 h, smaller capsules ( > 2 µm in diameter) suffered from reduced thermal stability.
Several core thickeners were identified as additives that improved core retention during high
temperature thermal cycling. However, the greatest improvement in thermal stability, for all
capsule size scales, was observed from the application of a poly(dopamine) coating developed
by Kang et al. [107].
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5.1 Materials and Methods
5.1.1 Encapsulation Method
Three types of double shell wall PU/UF capsules were prepared with various shell wall
compositions based on the method described in Caruso et al. [94]. In this method, a rapid
interfacial polymerization of polyurethane prepolymer (PU) occured to form an inner shell
wall, which was quickly followed by an in situ polymerization of urea formaldehyde (UF) to
form the outer shell wall. The three types of capsules refer to the three different size scales
outlined in Table 5.1.
An aqueous solution of shell wall ingredients (urea, ammonium chloride/ NH4Cl, resor-
cinol) and surfactant (EMA) was prepared. Then, a core solution of ethyl phenyl acetate
(EPA), polyurethane (PU) prepolymer (Desmodur L75), and optionally a core thickener was
emulsified in this solution. Type 3 capsules had an ultrahydrophobe, hexadecane, and a core
thickener, EPON 862, co-dissolved in the core solution for additional chemical stabilization.
For Type 1 capsules, only mechanical agitation (400 rpm) was used to create the emulsion
and control the capsule size (ca. 150 µm in diameter). After the core was emulsified, 20 min
was allotted for the PU to react before the addition of formalin. The mixture was then
allowed to react at 55◦C for 4 h to allow the outer UF shell wall to polymerize.
Type 2 capsules (ca. 1-2 µm) were prepared in a similar fashion with the added step
of homogenization (Omni International, GLH-115) to create a miniemulsion. The solution
was homogenized for 5 min at 17,500 rpm and then the agitation rate was reduced to
800 rpm for the remainder of the reaction. Formalin was added 10 min after homogenization.
Type 2 capsules were also prepared with a sonicator (Cole Parmer, 750 Watt), but a 10%
improvement in thermal stability was achieved using a homogenizer.
The size scale of Type 3 capsules (ca. 550 nm) was below the minimum emulsion size
possible using a homogenizer so the sonicator was employed to manufacture Type 3 capsules.
Capsules were sonicated for 2 min with a pulsing parameter of 0.2 s under mechanical
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agitation (800 rpm). Formalin was added 10 min after the sonication step. The amounts of
each chemical used in encapsulation for the three capsule types is given in Table 5.1.
Table 5.1: Parameters for capsule types.
Components Type 1 Type 2 Type 3
Average Diameter 150 µm 1.5 µm 550 nm
Aqueous phase 100mL H2O, 25mL
2.5% EMA
15mL H2O, 15mL
2.5% EMA
15mL H2O, 15mL
2.5% EMA
Urea 2.5 g 0.45 g 0.45 g
NH4Cl 0.25 g 0.1 g 0.1 g
Resorcinol 0.25 g 0.045 g 0.045 g
Formalin 6.33 g 1.2 g 1.2 g
Core 60 mL 5 mL 4.5 mL
Co-stabilizer None None 2.5wt%
Hexadecane
After the reaction was complete, the Type 1 capsules were rinsed three times (2 rinses in
DI H2O and the final rinse in ethanol) on a vacuum assisted filter to remove excess surfactant.
Dried capsules were sieved to be between 75 and 250 µm in diameter. Type 2 capsules were
centrifuged 3 times for 30 min at 4500 rpm in warm DI H2O and then lyophilized. Type 3
capsules were also centrifuged 3 times at 4500 rpm, but for 45 min. The additional time was
necessary to maximize collection of the nano-size scale capsules.
Some single shell wall capsules were also prepared for comparison. The UF only shell
wall capsules were prepared according to the method described by Caruso et al. [94]. The
procedure was identical to the technique used for Type 1 capsules, but without PU pre-
polymer. PU only shell wall capsules were prepared according to the method described by
Mangun et al. [20]. An aqueous solution of gum arabic (4.5 g in 40 mL) was prepared. A
mixture of 2.5 g of PU prepolymer in 20 g of EPA core solvent was added to the aqueous
solution at 400 rpm. The bath was heated to 60◦C and the PU was allowed to react for 2 h.
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5.1.2 Poly(dopamine) Coating
Select microcapsules were subjected to a second process, in which a coating of poly(dopamine)
(PDA) was uniformly deposited on the outer shell, following a process described by Kang
et al. [107]. Ammonium persulfate was used to oxidize the catechol moieties in dopamine
hydrochloride, thus producing quinine which polymerizes to form PDA. Microcapsules (3 g)
were added to 36 ml of buffer solution (pH=7.0), 0.66 g of dopamine hydrochloride, and
0.66 g of ammonium persulfate. The reaction was allowed to continue for 24 h at room tem-
perature under agitation. Capsules were then dried a second time using a vacuum assisted
filter.
5.1.3 Microcapsule Characterization
The microcapsule size distributions were obtained by image analysis of a minimum of 200
capsules. Scanning electron microscopy (SEM) was used to examine shell wall morphology.
The thermal stability of the capsules was evaluated using thermogravimetric analysis (TGA).
Isothermal TGAs were conducted at 180◦C. Mass loss was recorded as a function of time.
5.2 Results and Discussion
5.2.1 Microcapsule Size Distribution and Shell Wall Morphology
Representative size distributions of all three types of capsules are shown in Figure 5.1. Type 1
capsules had a rough shell wall exterior that was attributed to the deposition of colloidal
UF on the outer surface of the microcapsule. In contrast, Type 2 and Type 3 capsules had
smooth shell walls.
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Type 1 Type 2 Type 3
Figure 5.1: Representative size distributions and SEM images for the three types of capsules
in this study.
5.2.2 Capsule Thermal Stability
Capsule thermal stability at 180◦C was evaluated using thermogravimetric analysis (TGA).
As seen in Figure 5.2, Type 1 capsules with a double PU/UF shell wall were stable for 1 h
at 180◦C with minimal if any mass lost. In contrast, the thermal stability of PU only or UF
only capsules was significantly reduced. Each single shell wall microencapsulation could be
optimized further for the particular core material (EPA) to improve thermal stability, but
this was not a priority due to the success of the double shell wall capsules.
Figure 5.3 shows the results of thermal cycling on Type 2 capsules (ca. 1-2 µm in
diameter). About 20% mass loss was observed for the best case (3g PU/UF) and about
40% mass loss was observed for the worst case (9g PU/UF), where ‘3g’ refers to the amount
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Figure 5.2: Representative TGA traces that show the effect of increasing the amount of PU
prepolymer used in the encapsulation for Type 1 capsules with EPA as the core solvent. The
ratio of PU to UF did not effect the thermal stability of Type 1 capsules. However, single
shell walled capsules were significantly less stable. The legend notation refers the amount of
PU prepolymer dissolved per 60 mL core material.
of PU prepolymer per 60 mL of core material. An increase in shell wall thickness did not
directly correlate to an increase in thermal stability. We hypothesize that while the shell
wall thickness impacts the mechanical stability of the capsules, the degree of cross linking is
more important for thermal stability. Though the exact mechanism for the crosslinking of
the PU inner shell wall is unknown, interfacial polymerizations are slowed when reactant can
no longer easily diffuse through the membrane, which occurs as the polymer crosslinks [108].
Crosslinking potentially could be improved, but the proprietary nature of the Desmodur L75
PU prepolymer from Bayer makes selection of appropriate cross-linkers difficult.
Despite the success of the double shell wall technique for Type 1 capsules, the decrease
in thermal stability for Type 2 capsules was unsatisfactory. One method investigated to
improve the thermal stability of Type 2 capsules was the addition of a thickener to slow the
rate of solvent evaporation/ leaking from the capsule. From the above study, 3g PU/UF was
chosen as the shell wall composition, since it was the most thermally stable. The amount of
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Figure 5.3: Representative TGA traces that show the effect of increasing the amount of PU
prepolymer used in the encapsulation for Type 2 capsules with 3:97 EPON 862:EPA as the
core solution. More PU prepolymer did not lead to higher thermal stability. The legend
notation refers the amount of PU prepolymer dissolved per 60 mL core material.
polymer additive, 3%, was chosen since this amount produced an improved stability but also
was a minimal addition to the core solution. Depending on the healing chemistry, additives
either take away from the amount of healing agent delivered, or participate in the reaction. A
minimal amount of additive was selected for initial studies. Results are shown in Figure 5.4.
One of the best thickeners was EPON 862 resin, which increased the thermal stability
by 20% when compared to solvent (EPA) only. The addition of HMW PS (high molecular
weight polystyrene matched the performance of EPON 862 resin, but required longer to
dissolve in the EPA. A lower molecular weight PS (Mw=36 kDa) only improved the thermal
stability ca.10%. Lastly, one thickener actually lowered the thermal stability below that of
the plain EPA: poly (bisphenol A-co- ephichlorohydrin) (PBAE). This thickener may have
interfered with the polymerization of the shell wall.
Due to the superior performance and ease of dissolution, EPON 862 was selected for
thermal studies of Type 3 capsules. A comparison of all three capsule types with the same
core composition (3% EPON 862) and shell wall composition (3g PU/UF) is shown in
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Figure 5.4: Effect of various thickeners on Type 2 capsule thermal stability. The best thermal
stability was achieved by using EPON 862 as a core thickener.
Figure 5.5. Since the thermal stability of Type 3 capsules was reduced from the Type 1
and Type 2 capsules, more EPON 862 was added to the core to investigate if this would
improve the stability. A difference in performance was observed near the end of the thermal
cycle but no difference was observed up to 30 minutes at 180◦C (Figure 5.5).
5.2.3 Capsule Thermal Stability Repeatability
Thermal stability was further studied over a larger hold period and for different processing
conditions and repeated batches. The thermal stability varied from complete retention of
mass for up to 3 h at 180◦C to only ca. 20 wt % retention of mass in the worst cases.
Two representative TGA traces are given in Figure 5.6 showing a large change in thermal
stability.
A series of encapsulations were conducted to discern the critical encapsulation ingredient
responsible for the sudden loss of thermal stability (Table 5.2). The experiments showed
the relative insensitivity of the encapsulation procedure to a variety of variables except the
age of the Desmodur L75 prepolymer. The highest thermal stability was achieved when
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Figure 5.5: Comparison of thermal stability of all types of capsules. Capsules contained 3:97
EPON 862: EPA, except when noted otherwise. Thermal stability improved with capsule
size. For the smallest capsules, Type 3, additional polymer additive was added, but the
thermal stability was not significantly impacted.
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Figure 5.6: Representative TGA traces for good thermal stability achieved with un-aged
Desmodur L75 PU prepolymer and poor thermal stability typical of aged prepolymer.
the Desmodur L75 PU prepolymer was less than 6 months old and stored in a glove box
environment. Care was taken to minimize the time between removal of the Desmodur L75
from from its container to the addition into the core solution during the emulsification step.
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Table 5.2: Encapsulation variables and their effect on thermal stability
Batch Number Batch Description Desired Effect Improvement?
1 Replace PU prepolymer Improve reactivity of PU prepolymer Y
2 Increase RPM Decrease size1 N
3 Increase EMA concentration Decrease size1 N
4 Increase PU reaction time Increase PU crosslinking Y/N2
5 Double ammonium chloride Faster reaction/ Protect PU inner wall3 N
6 Decrease PU reaction time Faster reaction/ Protect PU inner wall3 N
7 Replacement of shell wall formers/ surfactant Remove contaminants N
8 Replacement of glassware Remove contaminants N
9 Soak mixer blades in acid Remove contaminants N
10 Use millipore water Remove contaminants N
11 Change pH to 3.4 Match prior pH conditions4 N
1 The average diameter seems to shift upward as the thermal stability worsens.
2 Normally 20 minutes are allowed before addition of formalin to allow the PU to cross link uninhibited by the formation
of UF. As the age of the PU prepolymer increases, more time is required to fully cross link the PU inner shell wall.
3 While UF capsules are perfectly spherical, PU/UF capsules often have small depressions which are attributed to defor-
mation of the PU inner shell before deposition of UF.
4 The pH of the aqueous solution should be between 2.6-2.7 before adjustment to 3.5. During these experiments the starting
pH was usually ca. 2.5 (slightly lower than previous encapsulations).
When exposed to high humidity, the shelf life of the Desmodur L75 was often shortened.
Some results also suggested allowing the capsules to soak in DI H2O for 24 h post encap-
sulation improved thermal stability. The improvement suggests that allowing more time for
water to react with the PU prepolymer leads to an increase in crosslinking and thus capsule
stability. Similarly, as noted for Batch 4, extending the time for the PU prepolymer to
react (uninhibited by the formation of the outer UF shell wall), also improved the thermal
stability in cases when the prepolymer was near the end of its shelf life.
5.2.4 Effect of poly(dopamine) (PDA) Coating
Kang et al. [107] recently developed a coating technique to improve the stability of cap-
sules in electrolytes for battery applications. In this technique, dopamine hydrochloride was
polymerized by oxidizing the catechol moieties using ammonium persulfate (Figure 5.7).
The poly(dopamine) deposited on the microcapsule shell producing a film that not only im-
proved the solvent stability, but also the thermal stability of dichlorobenzene (DCB) filled
PU/UF capsules. This coating technique was also highly successful at improving the thermal
stability of EPA-filled capsules (Type 1, Figure 5.8).
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PDA coating 
Core 
PU/UF 
PDA 
Figure 5.7: Scheme showing the polymerization of dopamine hydrochloride into
poly(dopamine), which is deposited onto a double shell walled microcapsule (adapted from
Kang et al. [107]).
Similarly, PDA coating also greatly improved the thermal stability of Type 3 capsules
(Figure 5.9). As discussed above, a small amount of core thickener was used to stabilize the
emulsion and provide extra thermal stability.
(a) (b)
Figure 5.8: Capsule stability of Type 1 EPA-filled capsules (3g PU/UF). (a) Dynamic and
(b) Isothermal TGA traces of both neat PU/UF capsules and PDA-coated capsules showing
an improvement in thermal stability from the PDA coating.
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Figure 5.9: Capsule stability of Type 3 capsules (3g PU/UF) with a PDA coating. The
core material was a mixture of 3:97 EPON 862: EPA, with 2.5 wt % Hexadecane (emulsion
stabilizer).
5.3 Conclusions
The thermal stability of three different size scales of capsules was evaluated by TGA. High
thermal stability was demonstrated for Type 1 (ca. 150 µm in diameter) capsules. Type 2
and 3 capsules (diameters > 2 µm) were less thermally stable and increasing the thickness
of the inner PU shell wall did not improve the thermal stability. The use of core thickeners
can aid the thermal stability slightly. The repeatability of thermal stability was discussed
and the age of the PU prepolymer was identified as a critical variable for thermal stability.
For all types of capsules, an additional PDA coat greatly improved the thermal stability
of the capsules. Thermally stable microcapsules have many applications, one being use
in a high temperature cured thermoplastic-toughened epoxy discussed in the next chapter
(Chapter 6), and a second being elastomers used in tire applications (Appendix D).
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Chapter 6
Solvent-based Self-healing in a
Thermoplastic-Toughened Epoxy
A new scheme for self-healing in a high temperature cured epoxy was explored using the
microcapsules developed in Chapter 5. The method employed a thermoplastic additive to
simultaneously toughen an epoxy and act as healing agent with the aid of an encapsulated
solvent to heal microcracks. Thermoplastics in combination with heat have been used to
repair crack damage, but these systems are not autonomous. The proposed autonomous heal-
ing process using solvents is shown schematically in Figure 6.1. Damage triggers rupture of
the microcapsules, which release solvent into the crack plane. The embedded thermoplastic,
which phase separates out of the host epoxy matrix during the cure process, is solvated and
redistributed, repairing the crack upon solvent evaporation.
capsule
epoxy
fiber
crack
thermoplastic
i) ii) iii)
Figure 6.1: Schematic of solvent-based healing strategy in a thermoplastic-toughened epoxy
showing (i) capsules embedded in a composite where a crack initiates and (ii) ruptures the
capsules, which locally dissolve the thermoplastic (brown) redistributing the thermoplastic
and forming a healed film upon evaporation (iii).
In this work, Type 1 (large ca. 150 µm in diameter) poly(dopamine)-coated microcapsules
were used to deliver sufficient healing agent to repair microcracking in a bulk polymer. After
screening several thermoplastic/ solvent combinations, poly(bisphenol A-co-epichlorohydrin)
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(PBAE)/ ethyl phenyl acetate (EPA) was selected. The results of this screening study and
supporting information for the work to follow is given in Appendix E. Self-healing was
achieved with up to 57% recovery of fracture toughness of the toughened epoxy. Healing
performance and fracture toughness of the microcapsule containing material remained sta-
ble after aging 30 days. The relative amounts of thermoplastic phase and the presence of
solvent-filled microcapsules influenced the storage modulus, Tg, and healing performance of
the polymer. Future work will focus on incorporating the thermoplastic/ solvent healing
system into a fiber-reinforced composite. In particular, some preliminary challenges associ-
ated with applying this healing chemistry to autonomous repair of fiber/ matrix debonding
are outlined.
6.1 Materials and Methods
6.1.1 Materials
Urea, ammonium chloride, resorcinol, formalin (37 wt % formaldehyde), octanol, dopamine
hydrochloride, ammonium persulfate, sodium phosphate monobasic, monohydrate, sodium
citrate dehydrate, ethyl phenyl acetate (EPA), diamino diphenyl sulfone (DDS), and poly
(bisphenol A-co-epichlorohydrin) (PBAE) were purchased from Sigma Aldrich and used as
received. Ethylene maleic-co-anhydride (EMA) copolymer (ZeMac E400, Vertellus) was
prepared in a 2.5 % w/v aqueous solution and used as a surfactant. Desmodur L75 was
generously supplied by Bayer as a polyurethane prepolymer. EPON 828 epoxy resin was
purchased from Miller-Stephenson. Araldite LY 8605 epoxy resin and Aradur 8605 hardener
was purchased from Huntsman.
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6.1.2 Preparation of Microcapsules
Capsules were prepared using a double shell wall technique previously described by Caruso
et al. [94] and Chapter 5. In this technique, polyurethane prepolymer (Desmodur L75)
undergoes a rapid interfacial polymerization forming the inner shell wall which is followed
by an in situ polymerization of urea and formaldehyde. An aqueous solution of surfactant
(EMA) and shell wall formers (urea, ammonium chloride, and resorcinol) was prepared and
the pH was adjusted to 3.5 by dropwise addition of sodium hydroxide. The core material
was comprised of ethyl phenyl acetate (EPA) and 0.05 g of Desmodur L75 per mL of EPA.
The core solution was then slowly added to the aqueous solution and allowed to emulsify
for 20 minutes at 400 rpm. Formalin was added to the encapsulation and the temperature
of the control bath was slowly ramped to 55◦C at 1◦C/min for 4 h. After the reaction was
complete, the microcapsules were dried on a vacuum assisted filter and sieved to be between
75 and 250 µm in diameter.
Dry microcapsules were subjected to a second process, in which a coating of poly(dopamine)
(PDA) was uniformly deposited on the outer shell, following a process described by Kang
et al. [107]. Ammonium persulfate was used to oxidize the catechol moieties in dopamine
hydrochloride, thus producing quinine which polymerizes to form PDA. Microcapsules (3 g)
were added to 36 ml of buffer solution (pH=7.0), 0.66 g of dopamine hydrochloride, and
0.66 g of ammonium persulfate. The reaction was allowed to continue for 24 h at room tem-
perature under agitation. Capsules were then dried a second time using a vacuum assisted
filter.
6.1.3 Characterization of Microcapsules
In addition to the TGA experiments conducted in Chapter 5, thermal stability was further
analyzed by using a hot stage mounted under an optical microscope. The samples consisted
of an aliquot of the thermoplastic/epoxy blend containing microcapsules between two cov-
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erslips. The thickness of the specimens was kept constant by using 280 µm glass beads as
spacers between the two coverslips. The samples were exposed to the same cure cycle as
bulk polymer specimens and images were taken throughout the cure process.
Some additional specimens were subjected to hygrothermal aging to determine the role of
water in capsule core loss. Thin sheets (0.5 mm) of capsule-loaded thermoplastic-toughened
epoxy were exposed to 70◦C at 95% RH in en environmental chamber (Cincinnati Sub-Zero
Industrial, MicroClimate) for up to 100 h.
6.1.4 Polymer Blend Preparation
A thermoplastic-toughened epoxy was prepared using a polymer melt-blend technique which
resulted in either 10, 15, or 20 wt % PBAE in the epoxy (32 pph DDS: EPON 828). The
thermoplastic, PBAE, was combined with EPON 828 at 150◦C for 4 h under vacuum and ag-
itation at 50 rpm. Once the thermoplastic/ resin mixture was homogenous, a stoichiometric
amount (32 pph) of resin hardener, DDS, was dissolved in the resin blend for 15 min under
vacuum. In select samples, 5 wt % microcapsules were added to the polymer and slowly
distributed. Then the entire mixture was placed in a vacuum oven to degas at 110◦C for
10 min. The material was poured into molds that were preheated to 150◦C. Once pouring
was complete, specimens were cured at 180◦C for 1 h. Both the ramp up to 180◦C (from
150◦C) and the cool down ramp were kept constant at 1◦C/min.
6.1.5 Preparation of Specimens for DMA
Dynamic mechanical analysis (DMA) was performed based on the ASTM Standard D5023-
07. Rectangular specimens (29.0 x 8.0 x 2.0 mm) were tested in three point bending (25 mm
span). The temperature was increased from 25◦C to 250◦C at 5◦C/min using a frequency of
1 Hz and a strain of 0.3%. The glass transition temperature was defined as the peak in the
tangent of the phase angle.
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6.1.6 Preparation of Fracture Specimens
Fracture specimens were prepared using a localized short groove TDCB specimen (Fig-
ure 6.6a) as previously described by Rule et al. [8]. To prepare TDCB specimens, Aradur
8605 hardener and Araldite Y 8605 resin were mixed (35:100 by weight), degassed, poured
into silicon rubber molds (with silicon rubber inserts) and cured at 150◦C for 20 min. The
silicone inserts were then removed and the active material (polymer blend described above)
was added to the insert region and cured.
The TDCB specimen geometry is crack length independent, which allows the fracture
toughness, K1c, to be simply calculated by:
K1c = αPavg, (6.1)
where α is a geometric constant. Here, α=11.2 x 103 m-3/2. Prior to testing, a precrack was
created using a fresh razor blade along the centerline of the specimen. Specimens were pin
loaded in Mode I tension under displacement control at a loading rate of 5 µm/sec until the
crack arrested at the end of the groove. Samples were then unloaded, allowing the crack
faces to come back into contact before evaluation of the healing performance.
6.1.7 Healing Performance Evaluation
Several sample types were used to evaluate healing performance and are summarized in
Table 6.2. Unless otherwise stated, 20 wt % PBAE was incorporated in all samples. Self-
healing samples were prepared with 5 wt % EPA-filled microcapsules and allowed to heal for
a specified amount of time at 30◦C. Two different reference tests (no microcapsules) were
carried-out to determine maximum healing efficiency. Specimens for type I reference tests
were fabricated with either 10, 15, or 20 wt % PBAE. Healing performance was evaluated by
manually injecting specimens with 5 µl of EPA after virgin testing and allowing specimens
to heal for a specified amount of time at 30◦C. For type II reference tests, specimens with
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20 wt % PBAE were heated to 180◦C for 1 h after virgin testing to determine the recovery
obtained after heat treatment alone. Three controls also were prepared without any ther-
moplastic additive (DDS: EPON 828) to confirm both PBAE and EPA were required for
healing. Control I specimens were manually injected with 5 µl of EPA in order to mimic
type I reference tests. Control II specimens were heated to 180◦C for 1 h after virgin testing
to compare to the performance of type II reference samples. The last control, control III,
contained 5 wt % microcapsules, in order to compare results to self-healing specimens.
Healing efficiency, η was defined as the ratio of the mode I fracture toughness of the
healed samples to that of the virgin samples. For the TDCB geometry this ratio simplified
to the ratio of the peak loads,
η =
K1c,healed
K1c,virgin
=
Pavg,healed
Pavg,virgin
. (6.2)
6.1.8 Single Fiber Microbond Specimen Fabrication
Microbond specimens consisted of a single fiber embedded in a microdroplet of either PBAE
or PBAE-toughened epoxy. Specimens with a thermoplastic (PBAE) matrix were prepared
by using a solvent casting technique onto a carbon fiber (Hexcel, IM7-Unsized). The thermo-
plastic was dissolved (25 wt %) overnight in EPA. A glass micropipette was used to deposit
the thermoplastic solution onto the surface of the fiber. The solvent was allowed 24 h to
naturally evaporate from the microbond specimens. The specimens were heated at 150◦C for
1 h under vacuum to remove any residual solvent. A second set of specimens was prepared
by allowing the solvent to evaporate entirely at room temperature. Specimens required ca.
1 week before the load displacement curves no longer displayed ductility due to residual
solvent in the matrix. The embedded length of all specimens was in between 80-120 µm.
PBAE/ epoxy blend specimens were prepared by heating an aliquot of the uncured blend
(prepared as described in Section 6.1.4) to ca. 120◦C and dipping a glass micropipette into
the polymer. Removal of the pipette caused the polymer to draw into a fibrous strand. This
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strand was brought into contact with suspended glass fibers (Owens Corning 158B-AA-675)
and a soldering iron was used to locally reheat the thermoplastic blend. The polymer then
readily formed discrete beads of the blend on the glass fiber. Specimens were cured at 180◦C
as described in Section 6.1.4.
6.1.9 Microbond Test Method
Optical images of the microbond specimens were obtained before testing in order to measure
the embedded length (le) of each specimen. The samples were tested with a custom-built
load frame and imaged simultaneously through a zoom lens to observe interfacial debonding.
Samples were loaded in displacement control using a linear actuator (Physik Instrumente)
translating at a rate of 0.5 µm/s and controlled through LabVIEW (National Instruments,
v10.0). Load was measured with a 150 g load cell (Honeywell Sensotec). Samples were
loaded to the maximum force (Pmax) needed to cause full interfacial debond. After debond,
the force dropped quickly and then slowly increased to a frictional plateau value (Pfriction).
The sample was then removed from the load frame and allowed to heal at 30◦C.
6.2 Results and Discussion
6.2.1 Matrix Morphology
The thermoplastic phase served to toughen the epoxy matrix as well as participate in crack
repair. The thermoplastic-toughening effect was a result of phase separation that occurs
during the cure cycle. SEM micrographs, shown in Figure 6.2, reveal a change in the phase
morphology as the amount of thermoplastic in the epoxy increased. At low loadings of
thermoplastic, small 1-2 µm particles of PBAE formed inside an epoxy matrix (shown in
blue). As the amount of PBAE increased, a co-continuous morphology developed, consisting
of thermoplastic particles in epoxy and isolated epoxy regions inside a thermoplastic matrix
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Figure 6.2: Phase separation in the thermoplastic/ epoxy blend. SEM images of the fracture
surface morphology (epoxy=blue, PBAE=gray) with increasing wt % PBAE: (a) 10 wt %
PBAE with small inclusions of PBAE in an epoxy matrix, (b) 15 wt % PBAE, and (c)
20 wt % PBAE, both showing a bi-continuous morphology containing both small PBAE
inclusions in an epoxy matrix and isolated epoxy regions in a PBAE thermoplastic matrix.
(grey). At higher loadings (≥25 wt %), complete phase inversion (continuous thermoplastic
matrix with isolated epoxy regions) occurred. Only a few specimens were prepared at these
loadings since viscosity was dramatically increased and specimen preparation was difficult.
6.2.2 Microcapsule Thermal Stability
Capsule integrity was further investigated during the cure of the thermoplastic/epoxy blend
on a hot stage under an optical microscope (Figure 6.3). Images at various stages of the
cure cycle are shown for both PDA-coated capsules (left) and uncoated capsules (right). The
amine hardener selected for this epoxy is solid at room temperature and was dissolved at
150◦C in the thermoplastic/ resin blend. Microcapsules were then distributed in the blend
and the entire mixture was degassed for 10 min. An aliquot of this polymer blend was
deposited on a preheated glass coverslip (also at 150◦C) under the microscope (Figure 6.3a-
b). At this stage of the cure cycle, the blend was homogenous since the viscosity/ degree
of cure of the epoxy was not high enough to induce phase separation. Also, both the PDA-
coated (Figure 6.3a) and uncoated (Figure 6.3b) capsules appeared spherical in shape and
undeformed, demonstrating that the mixing and degassing stages at high temperature did
not harm the microcapsules.
The phase separation began after ca. 45 min and was completed by the end of the 1 h
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Figure 6.3: Observation of PDA-coated (left) and uncoated microcapsule stability (right)
during cure. The cure cycle progressed from the addition of the hardener at 150◦C (a-b) to
1 h at 180◦C (c-d) and cooled down to room temperature. Microcapsule integrity is improved
by the addition of a PDA coating. Voids appeared ca. 100◦C (e-f) and grew slightly larger
upon reaching room temperature (g-h). We hypothesize these voids are water that diffuses
into the capsule at high temperature.
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at 180◦C portion of the cure (Figure 6.3c-d). Similar to the SEM images in Figure 6.2, a bi-
continuous structure was observed containing both a PBAE thermoplastic-dominant matrix
region (dark grey) and an epoxy dominant region (light grey). The microcapsules preferred
to reside inside the epoxy-rich phase, which was attributed to the compatibility of the UF
shell wall with epoxy. The PDA-coated capsules (Figure 6.3c) showed no deformation while
the uncoated capsules began to exhibit some wrinkling and shell wall collapse (Figure 6.3d).
After the epoxy was cured for 1 h at 180◦C, the material was cooled at 1◦C/ min. During
cool down a circular optical mismatch or void appeared inside both types of capsules ca.
100◦C (Figure 6.3e-f). These bubbles grew slightly larger as the cool down progressed to
room temperature (Figure 6.3g-h). For PDA-coated capsules the voids were the main type
of deformation observed (Figure 6.3g), while uncoated capsules also exhibited shell wall
collapse (seen as black spheres) or wrinkling (Figure 6.3h).
Surprisingly, voids did not appear in capsules exposed to thermal cycling in air or silicone
oil. Since immersion in epoxy was required to observe the void, one hypothesis is that the
void is actually water (or water vapor at high temperature) that diffuses into the capsules
during the cure process at 180◦C. During cool down the water vapor transforms back into a
liquid and crashes out of the EPA solvent. To test this hypothesis, a fully cured thermoplastic
toughened epoxy specimen (0.5 mm thick plate) was exposed to 70◦C and 95% RH and the
void size was tracked as a function of time. The size of the void was estimated as the ratio
of the diameter (D) of the void to the diameter of the microcapsule or:
V ol% = (
Dvoid
Dcapsule
)3. (6.3)
A clear increase in the size of the void was observed for increasing time. In contrast,
a specimen (same capsules, same batch of thermoplastic-toughened epoxy), showed almost
no change in the void size for the same amount of time (Figure 6.4) at room temperature
under ambient conditions. Furthermore, no voids were observed in capsules embedded in
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PDMS (Figure D.2), a more hydrophobic polymer. Unfortunately, water is prevalent in the
the atmosphere and compatible with many of the chemicals used in the thermoplastic/epoxy
blend. Attempts to produce specimens in water-free environment failed.
0 2 0 4 0 6 0 8 0 1 0 00
2
4
6
8
1 0
1 2
1 4
1 6
1 8
2 0
 
 
Cor
e L
oss
 (vo
l%)
T i m e  ( h )
 7 0 C ,  9 5 %  R H R T
Figure 6.4: Size of the void as a percentage of the capsule size for 20 wt % PBAE/ EPON
828: DDS with 5 wt % capsules. Specimens exposed to 70◦C and 95% RH showed an
increase in the size of the void compared to specimens aged at room temperature under
ambient conditions.
6.2.3 Modulus and Glass Transition Temperature
DMA (dynamic mechanical analysis) specimens with varying wt % of PBAE were prepared
to determine the modulus and the glass transition temperature of the PBAE-toughened
epoxy matrix (Figure 6.5 and Table 6.1).
Table 6.1: Summary of DMA results
wt %PBAE Capsule fraction (wt %) Tg E’
0 0 170 ± 3.0 3.2 ± 0.04
10 0 168 ± 0.9 3.2 ± 0.03
15 0 170 ± 2.8 2.9 ± 0.13
20 0 179 ± 6.3 2.9 ± 0.03
20 5 167 ± 2.3 2.6 ± 0.25
Representative DMA traces are shown in Figure 6.5a for a specimen with 20 wt % PBAE.
The storage modulus of the material remained constant until the glass transition temperature
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of the thermoplastic phase was reached (Figure 6.5a, peak 1). A slight drop occurred with
the softening of the thermoplastic phase and then a more precipitous drop at the Tg of the
epoxy (ca. 180◦C, peak 2). This dual peak behavior is typical of thermoplastic-toughened
epoxy systems.
a
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Figure 6.5: Effect of PBAE content on modulus and glass transition temperature. (a) Repre-
sentative DMA data for a 20 wt % PBAE specimen, where ¬ represents the Tg of the PBAE
phase and ­ denotes the Tg of the epoxy phase. (b) Average epoxy glass transition tem-
perature (Tg) and storage modulus as a function of wt % PBAE showing high Tg (¿150
◦C)
and modulus for all thermoplastic loadings. Error bars represent standard deviation.
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The effect of increasing the PBAE content on both glass transition temperature and
storage modulus is shown in Figure 6.5b. The Tg increased about 5% at the highest con-
centration (20 wt %) of PBAE while the storage modulus decreased slightly (ca. 9%). The
modest increase in glass transition temperature may be due to minimal amounts of thermo-
plastic being dissolved in the epoxy phase or formation of a graft copolymer [109].
Specimens were also prepared with 5 wt % microcapsules for DMA testing. Both the
glass transition temperature and modulus were reduced from the addition of microcapsules
(Table 6.1), but the glass transition temperature was within experimental error of the un-
modified epoxy (no PBAE, no microcapsules). Similar drops in both modulus and glass
transition temperature have been observed in prior work by Moll et al. [49].
6.2.4 Fracture Toughness and Healing Performance
TDCB specimens (Figure 6.6a) were healed for different lengths of time at two different
temperatures, 30◦C and 180◦C. Representative load-displacement curves for all sample types
(with 20 wt % PBAE) are shown in Figure 6.6 and a summary of all fracture testing results
is given in Table 6.2.
For all virgin tests, characteristic stick slip crack growth was observed. The average peak
load in the virgin test was calculated from the peaks in the load displacement data (denoted
by open blue circles in Figure 6.6) and the average load used to calculate virgin fracture
toughness (Equation 6.1) is shown by a blue dashed line.
Healing behavior for self-healing and type I reference tests was dependent on the amount
of time allotted for solvent evaporation. After 2 d, the healing curves gradually increased
to a peak load, which may be indicative of drawing or tearing of the thermoplastic phase
(Figure 6.6b,e). When the healing time was increased to 6 d, the load-displacement response
was more linear with near stable crack growth (Figure 6.6c,f). The average load in the healed
test was defined as the the average of the data between the beginning of deviation from the
initial slope and the end of crack propagation. For consistency, the point of deviation was
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Table 6.2: Fracture toughness and healing performance of specimens
Sample wt % Capsule Heal Heal K1c Healing
type PBAE wt % time Temp. (◦C) (MPa m0.5) efficiency (η)
Control I 0 0 2d 30 0.40 ± 0.08 0
Control II 0 0 1h 180 0.40 ± 0.08 0
Control III 0 5 2d 30 0.52 ± 0.03 0
Type I reference 10 0 2d 30 0.54 ± 0.05 0
Type I reference 15 0 2d 30 0.79 ± 0.04 0.53 ± 0.03
Type I reference 20 0 2d 30 0.98 ± 0.06 0.56 ± 0.03
Type I reference 20 0 4d 30 0.98 ± 0.06 0.68 ± 0.02
Type I reference 20 0 6d 30 0.98 ± 0.06 0.72 ± 0.03
Type II reference 20 0 1h 180 0.98 ± 0.06 0.68 ± 0.06
Self-healing 20 5 2d 30 1.23 ± 0.10 0.46 ± 0.02
Self-healing 20 5 4d 30 1.23 ± 0.10 0.48 ± 0.02
Self-healing 20 5 6d 30 1.23 ± 0.10 0.57 ± 0.04
Aging-15 days 20 5 6d 30 1.19 ± 0.06 0.57 ± 0.04
Aging-30 days 20 5 6d 30 1.17 ± 0.05 0.56 ± 0.04
calculated by finding the location of 10% offset from the initial slope. The points marking
the beginning and end of the averaged curve are denoted by open red circles in Figure 6.6.
Again, the calculated average load is shown by a dashed line (red).
Representative data for a type II reference specimen (with no solvent) healed at 180◦C
is shown in Figure 6.6d. The peak loads were on the same order of magnitude as the type I
reference tests with solvent injection (healed at 30◦C). However, a significant deviation from
the initial slope occurred in all type II reference samples tested, suggesting only part of the
virgin crack was healed.
Effect of Thermoplastic Concentration
To determine the effect of thermoplastic concentration on virgin fracture toughness and heal-
ing efficiency, we fabricated control and type I reference TDCB samples (no microcapsules)
with 0, 10, 15 and 20 wt % PBAE. As the amount of thermoplastic increased, so did the
virgin fracture toughness (Figure 6.7). The toughening effect was due largely to the change
in morphology that occurred with increasing PBAE concentration (Figure 6.2).
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Figure 6.6: Representative load-displacement curves for virgin and healed tests of specimens
containing 20 wt % PBAE. (a) Schematic of TDCB geometry for all tests. (b) Representative
load displacement curves for self-healing samples allowed to heal for 2 days and (c) 6 days.
(d) Load displacement curve for a type II reference sample exposed to a healing cycle of
180◦C for 1 h, (e) type I reference sample injected with 5 µl of EPA and allowed to heal for 2
or (f) 6 days. Dashed lines represent the peak load, Pavg, used to calculate healing efficiency.
Type I reference tests were conducted first to determine which loading of thermoplastic
exhibited the maximum healing potential. Results are summarized in Figure 6.7 and Ta-
ble 6.2. In each reference test, 5 µl of EPA was manually injected into the fracture plane
and the specimen was allowed to heal 2 d. During the allotted time, solvent locally dissolved
the thermoplastic and redistributed it in the crack plane. Specimens with 20 wt % PBAE
exhibited the greatest increase in fracture toughness as well as highest healing performance.
Similar trends were observed for 15 wt % PBAE. No healing was observed for 10 wt %
PBAE and the control case (0 wt % PBAE, control I). We suspect that 10 wt % PBAE was
insufficient to produce a continuous healed film. For the control case, solvent was unable to
heal the crack since the epoxy was fully cured.
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Figure 6.7: Effect of increasing the wt % of PBAE on fracture toughness and healing effi-
ciency (η) for type I reference specimens. At low wt % PBAE, minimal toughening occurs
and no healing was observed after injection of 5 µL of EPA and 2 d of heal time. With
20 wt % PBAE, the highest increase in toughness was observed and also the greatest healing
performance.
Effect of Microcapsules – Autonomous Healing
Microcapsules (5 wt %) were added to select specimens with 20 wt % PBAE to achieve an
autonomous healing response. A summary of healing results compared to both type I and
type II reference samples is given in Figure 6.8. The presence of microcapsules increased the
virgin fracture toughness (Figure 6.8a) of self-healing samples (26% compared to reference
samples). Control III samples also exhibited toughening due to the addition of microcapsules,
but no healing was observed without PBAE (Table 6.2).
As seen in Figure 6.6, healing performance was dependent on the amount of time allotted
for solvent evaporation (Figure 6.8b). Healing performance gradually increased to an average
of 57% recovery after 6 days of healing time for self-healing specimens. A representative
SEM image of a self-healing fracture surface after 6 days is shown in Figure 6.9. False color
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Figure 6.8: Summary of healing performance for all sample types. (a) Virgin fracture tough-
ness of self-healing specimens compared to reference samples. (b) Healing performance for
all sample types. Self-healing specimens showed an increasing trend in healing efficiency (up
to 57%), but at a slightly lower magnitude than reference tests due to the increase in virgin
fracture toughness. type I and II references show similar behavior with healing efficiencies
ca. 70%.
(purple) was added to the healed film to show the redistribution of PBAE that occurred
during the healing process and the subsequent tearing of thermoplastic during the healing
event.
100 µm
Figure 6.9: Colorized SEM image (purple=PBAE healed film) of an self-healing sample
healed for 6 days, which shows tearing that occurs during the healing event.
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The healing performance was compared to the response of type I reference tests, rep-
resentative of the maximum healing potential for this system. The peak loads during the
healing event for both type I reference tests and self-healing samples were similar, but the
higher virgin fracture toughness of the microcapsule-filled self-healing specimens led to a
reduction in healing efficiency. When compared to the neat thermoplastic-toughened epoxy
matrix (no microcapsules), healing efficiency reached an average of 72%. In contrast to type
I reference samples, control I specimens with no PBAE showed no recovery either after 48 h
at 30◦C, indicating that both PBAE and EPA are required for healing to occur.
The solvent-based healing system developed in the present work was compared with
prior studies in which heat was applied to achieve healing. A set of samples was exposed
to both 130◦C for 1 h (based off previous work by Hayes et al. [77]) or 180◦C for 1 h
(type II reference specimens). We observed no healing for samples exposed to 130◦C. We
hypothesize that high healing efficiencies are only attainable if the material is heated above
its glass transition temperature. Indeed, type II reference samples heated to 180◦C for 1 h
achieved 67% recovery of fracture toughness. Control II samples showed zero recovery after
the same healing cycle of 180◦C for 1 h.
Long Term Stability of Healing Performance
Self-healing samples were prepared and aged for up to 30 days at room temperature to
evaluate the stability of the healing performance and microcapsules. In contrast to prior
work by Caruso et al. [27], which relied on latent functionality of the matrix material,
healing performance and fracture toughness remained stable after 30 days (Figure 6.10).
The lack of dependence on reactivity of encapsulated components makes this system an
ideal candidate for long term aging studies.
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Figure 6.10: Effect of aging time on healing performance for self-healing samples with 20
wt % PBAE. Healing efficiency and fracture toughness remained constant after aging at
room temperature for 30 days.
6.2.5 Repair of Interfacial Debonding
As a first step toward incorporation of the thermoplastic/ solvent healing chemistry into
a fiber-reinforced composite, we conducted single fiber microbond tests to determine if the
thermoplastic/ solvent healing chemistry was able to repair fiber/ matrix debonding. Healing
of interfacial damage does not require large volumes of healing agent and therefore requires
significantly smaller capsules (ca. 1-2 µm in diameter). The size scale of capsules is important
for maintaining a fiber volume fraction in a fiber-reinforced composite. The issues with using
the current thermoplastic/solvent healing system to repair interfacial damage are discussed
below.
Initial attempts used the single fiber microbond protocol to repair damage between a glass
fiber (Owens Corning 158B-AA-675) and 20 wt % PBAE/ Epoxy blend. When no healing
was observed, a few single fiber specimens were embedded in Epofix epoxy and microtomed
to view the phase separation in the microbond sample. A ring of epoxy surrounded the
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fiber surface (Figure 6.11). To confirm the epoxy phase was surrounding the glass fiber,
an Energy-dispersive X-ray spectroscopy analysis (EDX) was completed. The presence of
sulfur in the curing agent was used to distinguish the epoxy phase from the surrounding
thermoplastic.
25 µm
Epoxy (EPON 
828: DDS)
Thermoplastic 
(PBAE)
Glass 
Fiber
EDX
Capsules
Figure 6.11: SEM backscatter image showing interfacial phase separation in PBAE-
toughened epoxy. Inset is from EDX where sulfur was used to mark the epoxy phase from
the thermoplastic. The epoxy phase completely surrounds the glass fiber.
Since the healing scheme requires the encapsulated solvent to redistribute the thermo-
plastic, interfacial phase separation is an obstacle to healing. The tendency for the epoxy to
prefer the interface of the glass fiber was attributed to the epoxy-compatible sizing present
on the surface of the fiber. A few fibers with different sizings were identified and evaluated.
Several sizings on glass fibers were recommended for compatibility with both thermoplastics
and epoxies, but in all cases the epoxy preferred the glass fiber interface. A similar effect
was observed with carbon fibers, with the exception of an unsized carbon fiber. In this case
alone, the thermoplastic was observed in some regions surrounding the fiber interface.
Single carbon fiber specimens using PBAE as the matrix droplet were prepared to eval-
uate repair of interfacial debonding using a thermoplastic/ solvent healing chemistry. The
PBAE was solvent cast onto the carbon fibers. Excess solvent was removed by either allow-
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ing the solvent to evaporate slowly over 7 days at RT or by heating the specimens for 1 h
under vacuum at 150◦C (denoted as “Heat” in Figure 6.12). Reference tests were conducted
by submerging single fiber specimens in EPA solvent and then allowing them to heal for up
to 6 days at 30◦C (Figure 6.12).
IM7U-Heat IM7U-RT IM7GP-Heat
0
20
40
60
80
100  Virgin IFSS Healed IFSS
 Healing Efficiency
 
 
V
ig
in
 IF
S
S
, H
ea
le
d 
IF
S
S
 (M
P
a)
H
ea
lin
g 
E
ff
ic
ie
nc
y 
(%
)
Sample Type
Figure 6.12: Effect of heat treatment on virgin IFSS and healing performance for a single
carbon fiber (IM7) embedded in a PBAE microdroplet. For comparison, an epoxy compatible
sizing (GP) is also included. The healed IFSS was similar in all cases, but the virgin IFSS
was noticeably improved by the heat treatment (thus reducing the healing efficiency).
The heat treatment increased the virgin IFSS significantly due to the residual stresses
from the mismatch in thermal expansion. The lack of heat treatment during the healing
event caused low healing efficiency. Indeed, microbond specimens that did not undergo a heat
treatment had high healing efficiencies because the process for deposition of the microbond
specimens was the same as for the healing event. The ability of a room temperature healing
event to match the improvement in IFSS due to high temperature cure remains a significant
challenge.
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6.3 Conclusions
A thermoplastic (PBAE)/ solvent (EPA) healing system was developed to overcome chal-
lenges related to thermal stability during commercial epoxy cure cycles and gradual loss
of functionality of reactive encapsulates. The effect of the PBAE on an aerospace-grade
epoxy, in terms of mechanical properties and fracture toughness, was quantified and used
to select the optimum healing system. Reference tests revealed this system was capable of
achieving healing efficiencies up to 72% and self-healing samples were able to recover up to
57% autonomously. Healed load-displacement response was similar for reference samples and
self-healing samples, which indicated that similar healed films were developed in both cases.
The decreased healing efficiency in self-healing samples was a result of increased virgin frac-
ture toughness due to the addition of microcapsules. Samples showed no change in healing
performance after aging at room temperature up to 30 days. Finally, several challenges for
application of this healing chemistry to recovery of IFSS were outlined.
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Chapter 7
Summary and Conclusions
7.1 Summary
Solvent-based healing strategies were developed for fiber-reinforced composites. Although
self-healing in polymeric materials continues to progress, composite materials present sig-
nificant technical challenges due to stringent manufacturing and performance requirements.
Here, methods to add capsule-based healing into a composite material without reducing the
fiber volume fraction or the cure temperature are explored.
First, a resin-solvent healing chemistry was used to achieve full recovery of interfacial
shear strength (IFSS). In order to maintain high fiber volume fractions, the size scale of
microcapsules needs to be reduced from prior work that used 100-200 µm diameter capsules
to a capsule size that is appropriate for the interstitial regions in a composite. Capsules
1-2 µm in diameter meet this size requirement and are appropriate for autonomous repair of
interfacial debonding, a key damage mode in composites. A microbond specimen geometry
consisting of a single glass or carbon fiber and epoxy microdroplet was adopted to evaluate
both the virgin IFSS and healing performance. The effects of capsule coverage, resin-solvent
ratio, and capsule size on recovery of IFSS were also determined, providing guidelines for
integration of this healing system into high fiber volume fraction structural composites. Next,
the protocol developed for glass fibers was successfully extended to repair high performance
carbon fiber/ epoxy interfaces. Methods to bind capsules to the fiber interface were required
and developed. Also, healing with nanocapsules was achieved with up to 91% recovery of
IFSS.
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Interfacial healing was then combined with repair of matrix cracking in a model composite
specimen. Glass fiber tows were embedded into a compact tension specimen and injection of
the resin-solvent healing chemistry was used to assess healing potential. As the number of
embedded fiber tows increased, the healing potential decreased to ca. 50%. We attributed
this reduction in healing performance to the inability of the current healing chemistry to
repair fiber fracture and the increase in crack separation. As a final step, microcapsules were
incorporated (a) at the interface of the fiber tows and (b) inside the epoxy compact tension
specimen to evaluate the effect of the microcapsules on crack propagation.
The success of the solvent-based healing approach motivated exploration of combinations
of thermoplastics and solvents as healing agents in fully cured matrices. In situ healing was
achieved with up to 57% recovery of fracture toughness in a high Tg, toughened epoxy cured
at 180◦C. The addition of both the thermoplastic phase and microcapsules tripled the frac-
ture toughness of the neat epoxy. Capsules with high thermal stability successfully survived
the high temperature cure cycle, which was critical for improving the Tg of self-healing
polymers. Furthermore, healing performance and fracture toughness of the microcapsule
containing material are stable after aging up to 30 days. Current limitations for application
of the thermoplastic/ solvent healing to repair of interfacial debonding were discussed.
7.2 Future Work
The resin-solvent healing system was successfully employed to repair interfacial damage.
Now, this chemistry is currently being incorporated into an in house prepregging line by
Kim and coworkers [102]. The incorporation of fiber functionalization (with capsules) into
the prepregging line addresses the issues of streamlining manufacturing and achieving a more
uniform capsule distribution throughout a high fiber volume fraction composite. However,
the main limitation of the resin-solvent chemistry is the requirement of an undercured epoxy
for healing, which is impractical for industry applications. One potential solution is to focus
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on small (ca. 1-2 µm) amine filled microcapsules. This has proved particularly challenging
due to the reactivity of the amine, the size scale of the amine molecule, and the tendency
for the amine to degrade the capsule shell wall. However, the improved stability from the
poly(Dopamine) coating might make amine encapsulation worth revisiting.
A second solution is to focus on the thermoplastic/ solvent healing system for autonomous
repair of a composite material. Here, a fully cured epoxy matrix could be used and the
system would only require a singular solvent-filled capsule, with minimal reactivity/ stability
issues. Two challenges that require further investigation are: (a) improvement of healing
efficiency with a reduction in time to heal and (b) repair of interfacial debonding. The
maximum of 72% recovery in neat specimens (instead of full recovery) was attributed to a
lack of bonding between the fully cured epoxy matrix and the thermoplastic phase during
healing. A complex three capsule system could be developed to initially prove full recovery
is possible, but is impractical long term. Perhaps a single capsule with co-encapsulated
amine and solvent could be stable and reactive enough to bond with both phases, but again
the encapsulation might be difficult. Ideally, if the bonding was perfected, the time to heal
would also be reduced to 24 h or less. An exothermic reaction that both improved bonding
between the phases and provided heat would be one way to speed up the redistribution of
the thermoplastic and evaporation of the solvent.
Unfortunately, interfacial repair was only successful for a room temperature cast thermo-
plastic, in which IFSS was significantly reduced. Also, for the thermoplastic/ epoxy blend,
the epoxy phase dominated the interfacial area, leading to no measurable recovery. Tailoring
of the fiber surface, or potentially even changing the thermoplastic, may be necessary to use
the thermoplastic/solvent combination to heal interfacial debonding. Additionally, the IFSS
of the bond during the healing event will have to be drastically improved in order to match
the IFSS that develops during a high temperature cure cycle. The deposition of a toughened
healing agent, perhaps by nanoparticles, is one method that could be used to toughen the
healed interface.
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The model composite test, with embedded fiber tows, has the potential to be used as a
screening test to evaluate a healing system before incorporation into a full composite. By
increasing tow spacing, the behavior of the specimen would more closely mimic a composite
with a crack perpendicular to a unidirectional ply. However, more research is required to
determine if the protocol is robust and suitable for self-healing. In particular, more tests
need to be completed to ensure this protocol is useful for a microencapsulated approach.
Also, application of a different healing system (such as the thermoplastic/ solvent system)
would be advantageous in oder to determine if the fiber tows are capable of improving
healing performance (via reinforcement or crack closure). Of course, it would be a significant
achievement to develop a healing system that could repair fiber fracture. From a mechanics
perspective, it would be interesting to study if this test could be used to link interfacial
debonding tests to full composite testing.
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Appendix A
Single Fiber Microbond Method
A single fiber microbond method was adopted to quantify autonomous recovery of interfacial
shear strength (IFSS). This method can be divided into three main parts: encapsulation,
fiber functionalization, and single fiber microbond preparation/ testing. The method de-
veloped here was optimized for resin-solvent healing after exploring the method previously
developed by Blaiszik et al. [44]. The changes made are expanded upon in the following
sections.
A.1 Encapsulation
A method to produce ca. 1 µm diameter DCPD-filled microcapsules was produced by
Blaiszik et al. [9]. Though this method could produce resin-solvent microcapsules of similar
size, the author made several changes to reduce polydispersity and the amount of unen-
capsulated core. Polydispersity was observed when comparing the volume percentage of
microcapsules with large diameters. The variables explored included the amount of surfac-
tant, EMA, the amount of ammonium chloride used in the encapsulation, and sonication
parameters. Of these variables, the sonication parameters had the largest influence on size
distributions. The EMA was varied up to 5 wt% in the solution with the goal of limiting coa-
lescence of core droplets, but no significant effect on the size distributions was observed. The
amount of ammonium chloride was increased in order speed up the reaction, thus decreasing
the amount of time before a stable wall formed, and provide some additional stabilization
during encapsulation. Though the amount was doubled, no effect was seen on the size dis-
90
tribution and capsule quality was reduced. The sonication parameters were varied from a
steady sonication for 3 min to a pulsing setting for 2 min. Pulsing sonication is able to more
efficiently break up droplets (Figure A.1). Longer pulsing times (i.e. 0.9 sec ON, 0.9 sec
OFF) were screened, but short quick pulsing was most effective in reducing the formation
of larger capsules.
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Figure A.1: Comparison of the volume percentage of microcapsules with a corresponding
diameter for steady sonication for 3 minutes and pulsed sonication (0.2 sec ON, 0.2 sec OFF,
2 min total time, which includes the OFF time). A significantly higher volume of capsules
have large capsule diameters with steady sonication.
The ratio of core to shell wall materials had little effect on the size distribution. However,
due to the relatively low volatility of a resin-solvent core and density near 1 g/ml, unencap-
sulated material was difficult to remove from an aqueous capsule solution. By reducing the
mass of the core material from 5.5 g to 5 g, the amount of unencapsulated material was min-
imized. Lower amounts of core material did not reduce the amount of unencapsulated core
further, and reduced the capsule yield per batch. Also, the 10 min delay for the emulsion to
stabilize before the addition of formalin was critical. Removing this 10 min wait resulted in
significantly more unencapsulated core.
As a secondary approach, PU/UF (polyurethane/ urea-formaldehyde) capsules were also
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investigated. This technique, originally developed by Caruso et al. [94] for large capsules (ca.
150 µm in diameter), is accomplished by adding a PU prepolymer into the core solution.
The PU prepolymer reacts with the surrounding water rapidly undergoing an interfacial
polymerization. After a 10 min wait, formalin is added to begin the UF in situ polymerization
according the the protocol already outlined in Chapter 2.1.1. The rapid reaction of the PU
inner shell wall tends to stabilize the droplets quicker, which produced in general smaller
capsule diameters (Table A.1) and less unencapsulated core. These PU/UF microcapsules
were used in select healing specimens, but did not produce noticeably different results that
UF only microcapsules. One of the main advantages of a PU/UF shell wall is the increased
thermal stability, which was not critical for the room temperature cured epoxy used in the
demonstration of interfacial healing, but is discussed at length in Chapter 5.
Table A.1: Comparison of the diameters of PU/UF capsules to UF capsules
Core Ratio (Resin:Solvent) UF Diameter (µm) PU/UF Diameter (µm)
0:100 3.7 1.6
3:97 2.1 1.6
10:90 1.7 1.7
This encapsulation protocol is capable of producing nanocapsules (with an average di-
ameter ca. 600 nm) with the use of an ultrahydrophobe for chemical stabilization. For the
case of a resin-solvent core, additional resin also aids in stabilization of the droplets likely
due to an increase in viscosity of the core droplet. Since resin participates in the healing
reaction, increasing the resin content slightly can also can also improve healing performance.
However, hexadecane (in quantities >2.5 wt%) is not soluble in solutions containing high
resin content and inhibits healing due to its low volatility in the crack plane. An alternative
ultrahydrophobe, dodecyl mercaptan (DDM) was investigated with the hypothesis that this
ultrahydrophobe could potentially participate in the reaction. This particular additive was
of interest since it had been used in prior work to stabilize emulsions by Landfester et al.
[110]. Unfortunately, no significant improvement was observed with this ultrahydrophobe in
healing performance. Also, though capsule stability (via TGA) was comparable, size distri-
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butions were more polydisperse with DDM (Figure A.2). More optimization is required to
utilize this ultrahydrophobe effectively.
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Figure A.2: (a) SEM image of nanocapsules prepared with DDM as the ultrahydrophobe
which shows polydispersity. (b) TGA traces of capsules prepared with the two ultrahy-
drophobes showing comparable thermal stability.
A.2 Fiber Functionalization
Fibers were functionalized using a dip coat technique from an aqueous suspension of micro-
capsules. First, microcapsules were centrifuged to remove excess surfactant and then used
at a known wt% (determined from TGA) in an aqueous solution as a sizing agent for fibers.
No pH adjustment was necessary to attract microcapsules to the surface of glass fibers (pH
ca. 3.3). Then, representative SEM images were taken to quantify capsule coverage (ξ):
ξ ≈ Npir
2
cap
pidle
, (A.1)
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where N is the number of capsules present on the surface of the fiber, rcap is the radius of
the capsule, d is the diameter of the fiber, and le is the embedded length of the fiber in the
microbond specimen. In order to quantify capsule coverage, images were transformed to a
binary image using ImageJ, shown in Figure A.3.
a
b
Figure A.3: (a) SEM image of a functionalized glass fiber with a red box denoting the region
of analysis for capsule coverage and (b) overlay of the same image modified for use of the
Analyze Particles routine in ImageJ.
First the ”Find Edges” option was used to improve the contrast of capsule boundaries,
followed by image thresholding and then the Binary option ”Fill Holes” (Figure A.3b). At
this point, the ”Analyze Particles” macro developed by ImageJ could be used to calculate
a percentage of the surface coated with capsules. This method was much quicker than the
previous technique used, which defines capsule coverage as:
ρ =
2N
pidle
. (A.2)
The new definition of capsule coverage (Equation A.1) also takes into account variations in
capsule diameter, which is not included in the prior work’s measurements.
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To control the capsule coverage (Equation A.1), SEM images were taken of fibers dip
coated as the wt% of capsules in the dip bath was varied (Figure A.4). The relationship
between capsule coverage and capsule concentration was linear up until a maximum coverage
near 70%. Above a capsule coverage of about 70%, capsules fully coated the fiber often
forming agglomerations and multiple layers of microcapsules.
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Figure A.4: Variation of capsule coverage (ξ) with increasing wt% of capsules in the dip
bath.
In contrast to glass fibers, microcapsules do not readily adhere to carbon fibers. Two
binder techniques were developed to improve capsule affinity to the carbon fiber surface:
(1) a two-step technique based on a low viscosity resin and (2) a one-step method where
capsules were added to an aqueous suspension of binder. For the first method, several epoxy
diluents were screened with the lowest viscosity agent leading to the most consistent capsule
coverages. For the second binder method, two aqueous epoxy suspensions (recommended
by Michelman Inc.) were investigated: HP302 and U601. HP302, a phenoxy-based binder,
provided much more consistent functionalization. The author hypothesizes this is related to
the relatively similar trends in ζ-potential with pH of the HP302 binder and resin-solvent
microcapsules (Figure A.5).
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Figure A.5: The ζ-potential with increasing pH of the two binders screened, U601 and
HP302, compared with nanocapsules (30:70 resin:solvent, 2.5 wt% hexadecane). The profiles
for HP302 and the nanocapsules were significantly more similar than the nano capsules
compared with U601.
A.3 Microbond Specimen Technique
Preliminary experiments used the specimen geometry and custom load frame developed
by Blaiszik et al. [44] (Figure 2.2). Resin-solvent microcapsules (3:97 resin:solvent) were
prepared using the technique outlined in Chapter 2.1.1 and functionalized onto single glass
fibers (Owens Corning 158B-AA-675). For this protocol, the resin system EPON 828: 40 pph
EPIKURE 3274 is applied to a glass slide using robotic arm deposition. The fiber function-
alized with microcapsules is then embedded perpendicular to the line of epoxy on top of two
fibers placed on either side of the line of resin. These two fibers parallel to the resin control
the space between the bottom of the microbond specimen and the functionalized fiber. Two
additional spacer fibers are placed on top of the functionalized fiber, again parallel to the
resin line and a wax coated coverslip is placed on top of the spacer fibers. The effect of
capsule coverage on IFSS and healing efficiency using this geometry is shown in Table A.2.
Though high capsule coverages were achieved, only ca. 50 % healing efficiency was
obtained. Caruso et al. [27] was able to achieve full recovery of fracture toughness using the
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Table A.2: Interfacial strengths and healing efficiencies for in-
creasing capsule coverage using the matrix EPON 828: 3274
Sample Virgin IFSS Healing Capsule No. of
Type (MPa) Efficiency, η Coverage, ξ Samples,n
SH-3274 34.1± 7.5 0.27 ± 0.09 0.08 4
22.2 ± 6.1 0.39 ± 0.08 0.25 5
15.7 ± 3.0 0.48 ± 0.05 0.59 7
Control1 21.1± 2.6 0.23 ± 0.06 - 27
Control2 20.5± 4.4 0.16 ± 0.05 - 14
1 Plain glass fiber embedded in EPON 828: 3274 using the
square specimen geometry from Blaiszik et al. [44].
2 Plain glass fiber embedded in EPON 828:3274 using the new
spherical specimen geometry
same resin-solvent healing chemistry, but with a different epoxy resin (EPON 828: DETA).
One hypothesis for the improvement using DETA as a hardener is the reduction in size of
the DETA molecule compared to the amines in EPIKURE 3274. Smaller molecules are likely
more easily pulled from the surrounding matrix by the solvent.
Unfortunately, application of method developed by Blaiszik et al. is impractical for the
matrix EPON 828: DETA. The primary obstacle is the long pot life (ca. 6 h) required
for specimen manufacture, to accommodate the robotic deposition step. For this reason,
and low sample yield with the aforementioned method, a new protocol was developed using
a spherical microbond geometry. The ease of sample preparation makes this technique
applicable to a much wider range of matrices.
With the selection of a new geometry, a fixture was manufactured to constrain the mi-
crodoplet. The fixture was comprised of two knife edges mounted on several micrometer-
driven stages for alignment. The fixture and protocol was validated by comparing the IFSS
from the previous method with a square specimen geometry (using EPON 828: 3274) and
the new spherical specimen geometry with the same matrix (Table A.2). The average IFSS
calculated from the new protocol was within the experimental error of the previous technique
developed by Blaiszik et al. [44].
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Appendix B
Characterization of a Carbon Fiber/
Epoxy Model Composite Test
A secondary goal of the tow-level work discussed in Chapter 4 was to determine the relation-
ship between fiber tow failure and interfacial debonding in order to predict the propagation of
fracture in a composite computationally. To complement this study, a single fiber microbond
specimen was used to evaluate interfacial bond strength and digital image correlation was
used to study strain fields around a transverse crack in a composite. Combined, the three
studies represent analysis of fracture at three different size scales: the simplest model com-
posite containing a single fiber and droplet of epoxy, a low fiber volume fraction (tow-level)
composite, and a full fiber-reinforced composite. Here, the materials system used for the
characterization of the model composite test was selected to be compatible with all three
studies.
B.1 Materials and Methods
B.1.1 Materials
The resin used was Araldite LY 8605 epoxy resin and Aradur 8605 hardener purchased
from Huntsman( stoichiometric ratio of 35 pph Aradur 8605 hardener). Resin was mixed,
degassed, and poured into the desired mold. Specimens were cured for 24 h at room tem-
perature followed by 2 h at 121◦C and 3 h at 177◦C for 3 h. Two types of glass fibers were
used for some initial studies: Owens Corning Type 158B-AA-675 and ECG 150 1/0 0.7Z
611/31 bn (PPG Inc.). The majority of the work was completed with AS4-3K carbon fibers
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(Hexcel) with various sizings (U: unsized, G: low level of epoxy-compatible sizing, GP: high
level of epoxy-compatible sizing).
B.1.2 Model Composite Fracture Test
Compact tension (CT) specimens were fabricated as discussed in Chapter 4 (Section 4.1.3).
Additionally, technical drawings of the fixturing and required molds are given in Appendix C.
Fibers were aligned perpendicular to the direction of crack propagation and spaced 5 mm
apart. The fracture samples were pulled in mode I tension at 5 µm/sec until the specimen
was either completely fractured or failed catastrophically.
Specimens were polished in order to visualize debonding. An optical technique suggested
by Bechel and Tandon [111] was employed to track the debonding region. A bright pipe
light was shown directly onto the fiber tow interface and the reflection of this light changed
as the fibers debonded. Post-mortem imaging of the specimens (again with a pipe light) but
using an optical microscope was used to determine the amount of debonding present at the
end of the test. Additionally, SEM was used to characterize the fracture surface.
B.1.3 Determination of Fiber Volume Fraction
The tow-level response was dependent on the local volume fraction of fibers. To determine
the local fiber volume fraction in select samples, specimens were sectioned and polished away
from the crack. An optical tiled image of an entire fiber tow was thresholded and then the
entire image was scanned to determine the fiber volume fraction in a given region (bounding
box). The size of the bounding box was varied from 100 x 100 µm2 to 600 x 600 µm2 in order
to determine dimensions that gave representative values for fiber volume fraction. Smaller
dimensions were more sensitive to small fluctuations in fiber volume fraction. A bounding
box size of 300 x 300 µm2 was selected since it gave normal distributions for two separate
fiber densities.
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Figure B.1: Effect of varying the bounding box on the calculation of fiber volume fraction
for a (a) loosely packed fiber tow and (b) densely packed fiber tow. A bounding box of 300
x 300 µm2 yielded a normal distribution for both densities of fibers.
B.2 Results and Discussion
B.2.1 Fracture Behavior of a Model Composite
The CT geometry with embedded carbon fiber tows was adapted to study the relationship
between fiber tow failure and debonding of the carbon fiber/ epoxy interface. An example of
a typical test is given in Figure B.2. With the addition of a pipe light, the reflection of light
off the surface of the carbon fibers illuminated the debonding region and crack progression.
In the beginning of the test, the crack propagated from the precrack region to the first tow
(peak 1). The load continued to rise until the crack drove past the first tow and arrested at
the second tow (peak 2). Though some small amount of debonding was observed before the
crack propagated to the second tow, a much larger amount of debonding was seen after peak
2. The load continued to rise until the first tow fractures (peak 3). Peaks 4 and 5 occurred
with the fracture of the second and third fiber tow respectively. The debonding was visible
in the form of bright edges near the crack, of which a closer look is given in Section B.2.3.
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Figure B.2: Representative load displacement curve with images taken throughout a tow-
level test.
SEM was used on select specimens (5 mm thick) to visualize the fracture of the fiber tows
post mortem. Though the imaging of the fracture surface does not give information about
how deep the debonding occurred, it does give an idea of the distribution of fiber strength
during the tow failure event.
Figure B.3: SEM image of a fiber tow in a CT specimen after a fracture event.
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B.2.2 Effect of Specimen Thickness
While ASTM 5045 recommends the thickness (B) of the specimen to be 1/4 of the width
(W, distance from loading line to end of specimen) of the specimen (W=60 mm), the load-
displacement response was relatively independent of thickness (Figure B.4). Thinner spec-
imens (3-4 mm) were originally investigated in order to maximize optical clarity of the
debonding region. However, with proper polishing, specimen thickness was not problematic.
A specimen thickness of 5 mm was selected because no arm failure was observed for this
thickness. A set of specimens with thickness of 15 mm were tested and the response was
similar in peak loads/ crack propagation as specimens prepared with B=5 mm.
Figure B.4: Effect of varying the thickness (B) of the CT specimen from 3-5 mm on load-
displacement response. S1 and S2 denotes the sample number.
B.2.3 Effect of Local Fiber Volume Fraction
Unlike like the specimen thickness, the local fiber volume fraction had a much larger effect
on the load-displacement response. For the sample set above, the fiber tow was spread flat
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making a rectangular region of fibers (Figure B.5). This led to a relatively low local fiber
volume fraction.
Figure B.5: Representative image of a fiber tow with a low density of fibers overlaid with a
contour plot of the calculated fiber volume fraction.
By increasing the fiber tension in the specimens, the fiber tows became more densely packed
leading to a circular region of fibers. Since the fiber count was constant (3K), this led to a
much higher local fiber volume fraction (Figure B.6).
The effect of changing the local volume fraction is seen in Figure B.7. First, a represen-
tative distribution across the center of the fiber tow is given in Figure B.7a. The two sets of
tests varied significantly in both the area of the fiber tow and the average fiber volume frac-
tion across that region. This difference noticeably affected the load-displacement response.
Much higher loads were observed when the tow was closely packed (Figure B.7b). Similarly,
the area of fibers debonded after the tow failed was much larger for specimens with a high
local fiber volume fraction. The author hypothesizes that once debonding initiates, it contin-
ues to propagate until the fiber tow fractures. By increasing the local fiber volume fraction,
the strength of the fiber tow increases until reaching the theoretical maximum (from the
manufacturer’s data sheet).
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Figure B.6: Representative image of a fiber tow with a high density of fibers overlaid with
a contour plot of the calculated fiber volume fraction.
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Figure B.7: (a) Representative fiber volume fractions in a high fiber volume fraction and
low fiber volume fraction specimen. (b) Effect of fiber volume fraction on load-displacement
response. Images showing the region of fiber debonding in a specimen with (c) high fiber
volume fraction and (d) low fiber volume fraction.
104
B.3 Conclusions
The CT geometry was successfully adopted for a model composite test and a fixture was de-
veloped to align fiber tows precisely. Fiber tension was used to control the local fiber volume
fraction of the fiber tows in the specimen. Local fiber volume fraction was characterized by
examining polished surfaces of fiber tows. The local fiber volume fraction had the largest
effect on both the load-displacement response and the interfacial debonding. Higher fiber
volume fractions led to higher loads before tow failure and thus a larger amount of interfacial
debonding.
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Appendix C
Fiber Tow Alignment Fixture
A fixture was designed to align fiber tows for a variety of molds. An optical image of the
fixture being used to suspend 5 glass fiber tows across two compact tension (CT) specimen
molds is shown in Figure C.1.
Figure C.1: Assembly of the fixture used to align fibers for a tow-level test specimen.
The fixture was designed to accommodate large plate molds (two glass sheets with a
gasket used to control the thickness) or smaller single molds (e.g. CT or TDCB). The space
in between the fiber alignment devices was large to allow both space for the molds and
clamps to keep fibers in place after removing molds from the fixture. Also, the height of
the center stand was variable to allow multiple mold thicknesses. Technical drawings of
the complete assembly and all the corresponding parts are shown below. The specific mold
master for the compact tension specimen used in Chapter 4 and Appendix B is also included
(Figure C.11).
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6ROLG:RUNV6WXGHQW(GLWLRQ
)RU$FDGHPLF8VH2QO\ Fixture Assembly
Figure C.2: Assembly of the fixture used to align fibers for a tow-level test specimen.
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 For Academic Use Only.
Figure C.3: Base plate that the tow-level test fixture was mounted to.
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Figure C.4: Angle bracket to raise the mold into alignment with suspended tows. Variable
to allow multiple mold thicknesses.
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Figure C.5: Central plate to mount molds to. Sizing selected to accommodate a region for
clamps to attach to the mold.
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Figure C.6: Stand that attaches to the central plate.
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Tow Alignment Comb
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Figure C.7: Tow alignment device. Grooves every 0.5 mm allow for precise alignment of
tows.
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Figure C.8: Stands for the tow alignment fixture. Suspended so that fiber tows could be
weighted for equal tension.
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Tow Support Rod
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Figure C.9: Guide to keep fiber tows from hitting sharp corner in the tow alignment grooves.
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Figure C.10: Stands to suspend fiber tow guide.
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Figure C.11: Technical drawing of the CT mold master used to make the PDMS molds for
CT specimens.
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Appendix D
Capsule Stability in Tire Applications
Capsules with high thermal stability have applications besides fiber-reinforced composites,
one of which is automotive tires. Here, both high thermal stability (up to 171◦C) and
mechanical stability are required to withstand the cure process and the harsh mixing process.
In tire processing, rubber is compounded using a Branbury mixer design. After evaluating
thermal stability by TGA (Chapter 5), microcapsules were mixed into both commercial
PDMS and tire rubber at Bridgestone research labs. The survival of these capsules and the
effect of the capsules on tensile properties is quantified below.
D.1 Materials and Methods
D.1.1 Incorporation of Capsules into Polymeric Matrices
Capsules were prepared according to the protocol outlined in Chapter 5. Capsules were first
incorporated into a commercial PDMS, Sylgard 184, to evaluate thermal stability and the
effect of capsules on mechanical properties. Type 2 and Type 3 capsules were mixed into the
initiator for Sylgard 184 and sonicated (Cole Parmer, 30 % intensity, 0.2 s pulsing parameter,
1 min) to improve the dispersion of microcapsules. Then the monomer was added to the
capsule/ initiator solution, degassed for 15 min, and cured at 180◦C for 15 min in a tensile
dogbone mold for tensile testing. Due to the size scale of Type 2 and Type 3 capsules, SEM
was also used to evaluate capsule survival.
Type 2 and Type 3 microcapsules with a core of 3% EPON 862: 97% EPA were added
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to tire rubber at Bridgestone research labs. Ten different samples were prepared that varied
with type of microcapsule, microcapsule loading (pph), and whether the rubber contained
carbon black. Once the capsules were incorporated, the rubber was hot pressed for either
15 min at 171◦C or 35 min at 145◦C. For each cure cycle, samples were prepared by either
water quenching post cure cycle or air cooling. Select samples were left uncured in order to
separate the effects of mechanical mixing and thermal cycling on the microcapsules.
D.1.2 Characterization of mechanical properties
Tensile tests were performed using capsule filled Sylgard 184 PDMS. The dimensions of
the dogbone specimens were 3.75 x 1.5 x 70 mm. Soft corrugated tabs were attached to
each side of the specimen using double sided scotch tape. Wedge-action grips were used
and clamped only half of each of the grip sections (the untapered sections) of the dogbone
specimens. Both the corrugated tabs and placement of the grips were required in order to
avoid failure in the grips. The specimens were pulled in tension at 1000 µm/ sec until failure
using LabView.
D.2 Results and Discussion
D.2.1 Capsule Survival in PDMS
Microcapsules were dispersed in Sylgard 184 and the resulting samples were sectioned in
order to visualize capsule survival using SEM. Representative images of Type 2 microcapsules
in Sylgard 184 are shown in Figure D.1. The SEM images showed crack tails, which are
indicative crack deflection and is consistent with prior studies of ca. 1 µm diameter capsules
embedded in epoxy.
Capsules were also visualized optically after thermal cycling (Figure D.2). The capsules
showed no deformation or voids (observed in prior work with epoxy).
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Figure D.1: SEM image of Type 2 capsules at a low magnification and high magnification
(inset).
Figure D.2: Optical image of capsules in Sylgard 184 after thermal cycling at 180◦C.
D.2.2 Capsule Survival in Tire Rubber
SEM was also used to evaluate microcapsule survival in tire rubber processed at Bridgestone
research labs. Representative images are shown in Figure D.3. A low magnification (2000x)
and high magnification (4000x) SEM image of Type 2 capsules cured at 171◦C for 15 min
and air cooled are shown in Figure D.3a and D.3b. Evidence of shell walls was present
in the fracture plane whereas no capsule shell walls were found in specimens that were
water quenched. A second cure cycle of 145◦C for 35 min was also explored and is shown
in Figure D.3c (air cooled). In contrast to the higher temperature cure cycle, many more
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capsule shell walls were in the fracture plan for the lower temperature cure cycle. Though
the lower temperature cure cycle using Type 3 capsules was not explored, Figure D.3d shows
that some Type 3 capsules were able to survive the 171◦C cure process for the case of air
cooling.
a b
c d
Figure D.3: SEM images of capsules in tire rubber. (a) Low magnification (2000x) of Type
2 capsules in gum stock cured at 171◦C 15 min (air cool) and (b) high magnification (4000x)
of the same composition. (c) Rubber stock with carbon black at the same low magnification
(2000x) of Type 2 capsules cured at 145◦C 35 min (air cool). (d) Type 3 capsules cured at
171◦C 15 min in gum stock (air cool).
In summary, for both capsule types, more capsules were present for air cooled samples
when compared to water quenching. Also, the lower temperature cure cycle was more
favorable for capsule survival. Capsule survival was loosely defined by the presence of shell
walls in the polymer fracture surfaces, though core retention could not be quantified. Though
the capsules appeared to undergo some mechanical deformation, it was hypothesized that
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the absence of capsules represents zero survival (seen in select samples).
The percentage of capsule survival was estimated by analysis of SEM cross sections of the
polymer cured at 145◦C for 35 min. The area fraction of microcapsules for full survival was
calculated based on an average capsule diameter and the amount of microcapsules added
to the tire rubber. This area fraction was compared to the area fraction of microcapsules
observed in each SEM cross section in order to calculate a percent survival (Figure D.4).
Figure D.4 shows that most of the images analyzed exhibited 15-20% survival, with a maxi-
mum of 25% survival observed in several cases. Images were also taken of specimens before
the cure process and the presence of microcapsule shell walls was similar. This suggests that
mechanical damage during the mixing process could have a stronger influence than cure
temperature. Suggestions for improving protection of the microcapsules during the mixing
process are given in the conclusions.
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Figure D.4: Distribution of the survival percentage of microcapsules in subjected to tire
processing and curing conditions.
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D.2.3 Effect of Capsules on Mechanical Properties of PDMS
Particulate additives are used in many polymers to improve or change the mechanical prop-
erties. Here, Type 2 and Type 3 capsules were added to PDMS to evaluate the effect of
capsule fillers on tensile properties. Poor dispersion of microcapsules led to stress concen-
trations that lowered the UTS of the material, but the addition of sonicaton to the mixing
process ameliorated this issue. Two capsule loadings were investigated: 0.5 and 1 wt %. As
shown in Figure D.5, the addition of Type 2 capsules minimally affected the UTS of Sylgard
184 for both capsule loadings. The addition of Type 3 capsules reduced the UTS further
than Type 2 capsules likely due to issues with dispersion and survival of Type 3 capsules
during the cure cycle.
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Figure D.5: Comparison of UTS for control Sylgard 184 specimens (no capsules) and speci-
mens prepared with both Type 2 and Type 3 capsules.
A summary of results for tensile specimens is given in Table D.1. The percent reduction
in UTS from the addition of capsules to neat polymer (control specimens) is given for each
sample type.
122
Table D.1: Summary of Tensile Tests in PDMS
Sample Type Capsule fraction (wt %) UTS (MPa) % Reduction
Control 0 5.9 ± 2.7 -
Type 2 0.5 5.1 ± 2.1 14
1 4.6± 2.0 22
Type 3 0.5 4.1 ± 0.9 31
1 3.6 ± 0.8 39
D.2.4 Effect of Capsules on Mechanical Properties of Tire
Rubber
Tensile tests were additionally conducted at Bridgestone research labs on tire rubber spec-
imens filled with microcapsules. The effect of the capsules on the UTS was negligible, but
capsule survival was not optimized as discussed above.
D.3 Conclusions
Microcapsules with high thermal stability were successfully incorporated into both Sylgard
184 and tire rubber at Bridgestone research labs. Evidence of survival was present in tire
rubber post representative tire processing conditions. The UTS of the rubber was tested at
Bridgestone and was not reduced, but the SEM results from UIUC suggest that microcapsule
survival may not have been optimized. Some suggestions for improvements include: adding
the microcapsules into the dispersion oils to protect them during the mixing process, using
the lower temperature cure cycle (145◦C, 35min) and air cooling, or adding a protective
coating to the capsules to further improve mechanical/thermal stability.
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Appendix E
Thermoplastic-toughened Epoxy
High temperature cures are required to produce an epoxy with superior mechanical proper-
ties. However, high temperature cure cycles present significant challenges for capsule-based
self-healing systems, where capsule integrity is affected by thermal cycling. With the goal
of producing a high performance self-healing matrix material, a thermoplastic is blended
with an aerospace grade epoxy: EPON 828 epoxy resin cured with diamino diphenyl sul-
fone (DDS) at 180◦C. Thermoplastics are common additives to increase toughness in epoxy
materials in industry. More recently, some self-healing materials utilize this thermoplastic
phase to heal microcracks with the application of heat. Here, we use a thermoplastic with
the addition of an encapsulated solvent to produce autonomous healing. With careful selec-
tion of both thermoplastic and solvent, healing is achieved in toughened material cured at
180◦C with an encapsulated healing system. The highest performing system, PBAE/EPA
(poly(bisphenol A-co-epichlorohyrdin)/ethyl phenyl acetate) is discussed in depth in Chapter
6, with supporting information provided here in the following Appendix.
E.1 Thermoplastic selection
Thermoplastics were selected based on use in epoxy-toughening or self-healing literature and
screened for solubility in high boiling point solvents capable of surviving a high temperature
cure cycle. From epoxy-toughening literature, PES (polyethersulfone) and PSF (polysul-
fone) were the most common thermoplastic additives to toughen epoxy. From self-healing
literature, three thermoplastics capable of crack healing with heat were selected: PBAE
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(poly(bisphenol A-co-epichlorohydrin)), PCL (poly(caprolactone)), and EMMA (ethylene
methyl methacrylate). Each of these polymers was submerged in various encapsulatable sol-
vents for 24 h and the uptake of solvent was measured (Figure E.1). PES and EMMA were
minimally soluble in any of the solvents screened. PCL and PSF were highly soluble in all
benzene solvents (iodobenzene/IB, chlorobenzene/CB, dichlorobenzene/DCB) and PBAE
was soluble in EPA and PA (phenylacetate). Of the solvents that were compatible with each
polymer the highest boiling point solvent was selected in order to provide the highest ther-
mal stability. This led to three thermoplastic/solvent pairs that were further investigated:
PCL/IB, PSF/IB, and PBAE/EPA.
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Figure E.1: The percent increase in mass of solvated thermoplastics.
Each thermoplastic/solvent pair was evaluated for its ability to repair damage due to
fracture using a tapered double cantilever beam (TDCB) protocol previously reported by
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Brown et al. [3, 4], where fracture toughness, KIC , is defined as:
KIC = αPC , (E.1)
and α=11.2 x 103 m-3/2. To save material a localized TDCB specimen geometry suggested
by Rule et al. was utilized [8]. In these initial studies, the peak load in the virgin test,
PCvirgin , was calculated as the average of the peaks in the load displacement curve. The
peak load in the healed test, PChealed , was defined as the maximum load sustained during
crack propagation during the healed test.
TDCB specimens made of epoxy with varying amounts of thermoplastic were pulled
in tension at 5 µm/sec, fractured, and the effect of the thermoplastic on virgin material
properties was quantified. Solvent or 10 wt % thermoplastic in solvent was manually injected
into the crack plane and samples were allowed to heal for 48 h at room temperature. A
summary of the healing performance for 20 wt % thermoplastic in EPON 828: DDS is
shown in Figure E.2.
Figure E.2: Selection of thermoplastic. Healing performance of three different thermoplas-
tic/solvent pairs showing minimal performance for PCL/ IB and the highest performance
for PBAE/ EPA.
Poly(caprolactone) (PCL) was used by Luo et al. [79, 80] with heat to repair crack
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damage. Though PCL was soluble in iodobenzene (IB), no recovery of fracture toughness
was observed even for a high loading of PCL (20 wt %) using the TDCB protocol. Polysulfone
(PSF), a thermoplastic common in epoxy-toughening literature [112], was also soluble in IB,
and showed early promise with moderate recovery. However, IB is relatively toxic and has a
high density (1.8 g/ml), which caused capsules to sink instead of remaining well dispersed in
the matrix material. The work completed with PSF/IB is discussed more fully in Section E.2.
E.2 Polysulfone/ Iodobenzene Healing
E.2.1 Polymer Blend Preparation
PSF pellets were purchased from Sigma-Aldrich and used as received. The PSF (10 wt %)
was first dissolved in DCM (dichloromethane) overnight. Then the DCM/PSF solution
was added to EPON 828 resin at 80◦C. Once a homogenous mixture was obtained, the
resin/solvent/thermoplastic solution was degassed at 80◦C overnight to remove excess sol-
vent. The blend was heated to 150◦C in order to add the hardener, diaminodiphenyl sul-
fone (DDS). The manufacturer’s recommended ratio (25 pph) was added to the thermo-
plastic/resin blend. The stoichiometric ratio (32 pph) was explored in future work due to
surprisingly low glass transition temperatures obtained with 25 pph DDS (Section E.3.3).
However, for all the initial studies the ratio of DDS to EPON 828 was 25 pph. Once the
DDS was dissolved, the thermoplastic/epoxy blend was degassed for 10 min at 110◦C and
poured into preheated molds.
To prepare TDCB specimens, Aradur 8605 hardener and Araldite Y 8605 resin were
mixed (35:100 by weight), degassed, poured into silicon rubber molds (with silicon rubber
inserts) and cured at 150◦C for 20 min. The silicone inserts were then removed and the
active material (polymer blend described above) was added to the insert region and cured.
A longer cure cycle of 180◦C for 3 h was used in initial studies, based on prior work by Luo
et al. [79], which was later modified/shortened to allow maximum capsule survival. The
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effect of several cure cycles is discussed in Section E.2.3.
E.2.2 Determination of Healing Cycle
As mentioned above, short groove localized TDCB specimens were used to evaluate healing
performance. In an initial study, three different loadings of PSF were incorporated in TDCB
specimens: 14 wt %, 19 wt %, and 24 wt % (20% PSF: EPON 828, 30% PSF: EPON 828,
and 40% PSF: EPON 828). The purpose of this study was to determine critical variables for
maximum healing performance. One of the first properties observed was phase separation,
which is common in thermoplastic/ epoxy blends. Figure E.3 shows the effect of increasing
thermoplastic concentration on fracture surface morphology and phase separation. At low
wt % PSF (e.g 7 wt %, Figure E.3a) small particulates of PSF (grey) were observed in
an epoxy matrix (blue). As the amount of PSF was increased (ca. 14-19 wt % PSF,
Figure E.3b), a bi-continuous structure was observed including both PSF particulates in an
epoxy matrix and epoxy spheres in a thermoplastic matrix. At higher wt % PSF (24 wt %,
Figure E.3c), complete phase inversion was observed.
10 µm10 µm 20 µm
a b c
Figure E.3: Effect of increasing the wt % of PSF. (a) Low wt % (ca. 7 wt %) of PSF in
EPON 828: DDS exhibiting thermoplastic particulates (grey) in an epoxy (blue) matrix.
(b) Bi-continuous phase separation and (c) full phase inversion.
After virgin testing, specimens were injected with IB and allowed to heal for various
times. In Figure E.4a, the effect of healing time on healing efficiency showed an improvement
with extended time until a plateau was reached shortly after 48 h. Also, with increasing
wt % PSF, higher healing efficiencies were obtained due to an increase in available healing
agent. However, at the highest wt % PSF tested, complete phase inversion lowered the virgin
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fracture toughness (Figure E.4b) and made specimens difficult to mold. The thermoplastic
loading of 20 wt % had the highest recovery of virgin fracture toughness while still doubling
the unmodified fracture toughness of EPON 828: DDS.
a b
Figure E.4: (a) Effect of healing time on healing efficiency for 3 different wt % of PSF in
EPON 828/ DDS. Small reduction in performance for healing cycles of 24 h, after which a
plateau in healing performance was reached between 48-72 h. (b) Summary of virgin fracture
toughness and reference tests (injection of 5 µl of IB) for various wt % of PSF.
To probe the results in Figure E.4, SEM images of fracture surfaces were also taken.
In Figure E.5, the effect of extended heal time is observed. For a healing time of 24 h,
the fracture surface had a smoother texture and the polymer appeared to still be solvated
(Figure E.5a). As the heal time was increased to 96 h, the fracture event appeared similar
to tearing of unsolvated polymer (Figure E.5b). As discussed in Chapter 6, this effect was
manifested in the load displacement response as a transition from a sloping curve to a flatter
curve with increasing heal time.
E.2.3 Effect of Cure Cycle
The initial cure cycle of 3 h at 180◦C was detrimental to IB PU/UF microcapsules since
the boiling point of IB is 188◦C (only slightly higher than the cure temperature). A cure
temperature of 150◦C was selected as an elevated cure temperature with suitable capsule
stability. To determine the length of cure, DSC experiments were run to determine the
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a b
Figure E.5: SEM images of fracture surfaces after different healing cycles. (a) SEM image of
a specimen (19 wt % PSF) allowed to heal for 24 h suggesting the polymer is still solvated.
(b) SEM image of a specimen (19 wt % PSF) allowed to heal for 96 h which shows a tearing
failure of the thermoplastic.
Table E.1: Summary of the degree of cure and glass transition temperature due to a cure
cycle at 150◦C
Time (h) Degree of Cure Tg(
◦C)
3 96 91
5 100 116
8 100 131
12 100 132
24 100 139
degree of cure and the glass transition temperature (Table E.1).
After 8 h at 150◦C, the glass transition temperature appeared to plateau and only a
minor increase in Tg was observed for tripling the cure cycle time to 24 h. Thus a cure cycle
of 150◦C for 8 h was selected for TDCB testing. The effect of the lower temperature cure
cycle on virgin fracture toughness and healing performance is shown in Figure E.6. These
tests were again reference tests with injection of the healing agent, but here a 10 % PSF/
IB mixture was injected. As seen in Figure E.2, injection of IB alone and injection of a 10%
PSF/IB solution yielded similar healed fracture toughness values.
For the lower temperature cure, both the virgin fracture toughness and the healing per-
formance were reduced when compared to the 180◦C cure cycle. Often higher degrees of
cross linking are achieved during higher cure temperatures and so it is unsurprising that the
virgin fracture toughness was reduced. Interestingly, the peak loads for healed specimens
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Figure E.6: Summary of reference tests (injection with 10 wt % PSF/ IB solution) for
specimens cured at 150◦C for 8 h. Both healing performance and virgin fracture toughness
was reduced by the lower cure temperature.
were also reduced. Fracture surfaces of the thermoplastic-toughened epoxy matrix cured
at three temperatures are shown in Figure E.7. The lowest cure temperature, 120◦C for
24 h (Figure E.7a), had a tortuous fracture surface and the phase separation occured on a
smaller length scale. As the cure temperature was increased to 150◦C for 24 h (Figure E.7b),
the length scale of the phase separation increased leading to larger continuous areas of each
phase. For comparison, the original 180◦C for 3 h cure cycle is shown in Figure E.7c, which
exhibited the largest continuous regions of either phase. Though fracture surface tortuos-
ity often aids healing performance due to increased available surface area for bonding, we
hypothesize that in this case, the large crack separations that accompanied this tortuosity
were not advantageous for healing, particularly solvent healing.
E.2.4 Exploration of Bisphenol A-capped PSF
In a study by Hedrick et al. [113], the virgin fracture toughness of an 828/DDS epoxy
was doubled by the addition of a Bisphenol A end capped PSF (Bis A-PSF). The end cap
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a b c
Figure E.7: Effect of cure temperature on fracture surface morphology. SEM images of
14 wt % PSF in EPON 828:DDS cured at (a) 120◦C for 24 h, (b) 150◦C for 24 h, and (c)
180◦C for 3 h. With increasing temperature each phase became more continuous leading to
an increase in the characteristic length scale between the two phases.
was designed to improve bonding between the thermoplastic and the epoxy matrix. The
reaction itself proved highly sensitive to oxygen (leading to a purplish color) and water,
which repeatedly caused issues achieving high molecular weight polymers (>10 kDa). High
molecular weight polymers were required to obtain an improvement in fracture toughness.
For all polymers synthesized and various attempted cure cycles, the virgin fracture toughness
was not improved from as received PSF. This could have been caused by inconsistencies in
the molecular weight of the polymer or contaminants. Possible contaminants included excess
salts or residual solvents from the reaction.
E.2.5 Summary
The PSF/ IB healing chemistry showed moderate recovery and doubled the virgin fracture
toughness when compared to unmodified epoxy, EPON 828:DDS. Though the challenge
of capsule dispersion is an issue for bulk polymer studies, this healing chemistry still has
potential for interfaces where the capsules could be directly applied to the surface of a fiber.
Furthermore, the ability to tailor the healing chemistry by end capping the polymer may
yield more options than the PBAE/EPA healing chemistry in future work.
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E.3 PBAE/EPA Healing
The last thermoplastic explored from the initial screening tests, poly(bisphenol A-co-epi-
chlorohydrin) (PBAE), was selected for further studies since it yielded the highest healing
performance and greatest improvement in fracture toughness. Also, PBAE dissolved well in
EPA, a green solvent with a reasonable density (1.06 g/ml). In addition to a stable capsule
distribution due to the density of EPA, the higher boiling point (225◦C) allowed higher cure
temperatures to be achieved. Though the bulk of the work on this system is provided in
Chapter 6, some supporting information is provided in the following sections.
E.3.1 Polymer Blending and Preparation
The PBAE/ epoxy blend was prepared using a polymer melt-blend technique. The thermo-
plastic, PBAE, was combined with EPON 828 at 150◦C for 4 h under vacuum and agitation
at 50 rpm. Due to the viscosity of the resin/ thermoplastic blend, faster mixing speeds were
not possible with the magnetic stir bar. Mechanical mixers were also used for select samples,
but a slow stir rate under constant vacuum with a magnetic stir bar produced samples with
the least amount of voids. Once the thermoplastic/ resin mixture was homogenous, the resin
hardener, DDS, was dissolved in the resin blend for 15 min under vacuum (at 150◦C). For
the first 10 min the DDS was mixed into the blend using the magnetic stir bar. Then the
stir bar was quickly removed and thermoplastic/epoxy was degassed for the final 5 min at
150◦C. In select samples, microcapsules (preheated for 15 min at 110◦C) were added to the
polymer and slowly distributed. Then the entire mixture was placed in a vacuum oven to
degas at 110◦C for 10 min. The lower degassing temperature step was adopted to remove
voids from the distribution of microcapsules. Attempts to degas a capsule loaded mixture
at 150◦C led to an increase in capsule rupture.
Fracture specimens were prepared using a localized short groove TDCB specimen as pre-
viously described for PSF/ IB specimens. Voids and surface defects from thermal mismatch
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and the high viscosity of the blend were difficult to control/ minimize. The most important
factor in reducing voids was ensuring the thermoplastic/epoxy blend was always at a lower
temperature than the surrounding molds, which prevented the blend from cooling rapidly
and trapping air. The most effective method used was pouring the resin inside the oven
onto molds that had equilibrated to 150◦C (Figure E.8). The material was allowed to flow
down the insert section of the TDCB (on the bottom half of the mold). The bottom was
then removed from the oven and allowed to cool slightly before the top of the mold was
slowly pressed into the material. Specimens were placed back into the oven to allow the
top mold to slowly sink into the blend and the whole specimen returned to 150◦C. After all
specimens were poured (ca. 30 min), specimens were clamped with 4 metal clamps each and
stood upright (the high cure temperature required additional clamping force to keep resin
contained). Due to the viscosity of the material, only 4 samples could be poured before the
epoxy began to cure and increase the viscosity further. The entire molding process was held
constant at 45 min (at 150◦C).
Figure E.8: Photo of the pouring fixture inside the oven.
E.3.2 Effect of Cure Cycle
As discussed Section E.2.3 for the the PSF/IB system, the original cure cycle of 180◦C for
3 h was detrimental even for the EPA filled microcapsules, despite the higher boiling point.
Virgin fracture toughness was maximized for 20 wt % PBAE, but 15 wt % PBAE was also
explored since the percentage of recovery was similar. In Figure E.9, the effect of reducing
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the cure cycle temperature to 160◦C (for 3 h) shows similar results to the PSF/IB system:
a reduction in healing performance and fracture toughness.
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Figure E.9: The effect of the cure temperature on virgin and healed fracture toughness for
TDCB specimens with (a) 15 wt % and (b) 20 wt % PBAE.
E.3.3 Effect of Stoichiometry
As mentioned previously, all PSF/IB work and all work with PBAE/EPA in the sections
above was completed using an amine (DDS) ratio of 25 pph according to the manufac-
turer’s recommendation. However, the Tg using this ratio was relatively low (ca. 130
◦C)
for the cure temperature of 180◦C. To obtain the Tg, DMA experiments were conducted.
Specimens were prepared as described above (Section E.3.1), with the exception that the
thermoplastic/epoxy blend was poured into a 2 mm thick plate mold. Specimens were then
sectioned into 2 x 8 x 29 mm rectangular bars and tested in three point bend (following
ASTM D5023-07).
Surprisingly, by changing the amine ratio from 25 pph to 32 pph (stoichiometric ratio),
an almost 40◦C improvement in Tg (Figure E.10) was observed. This occurred for both
the unmodified epoxy, EPON 828:DDS, and the thermoplastic toughened epoxy. In Fig-
ure E.10b, a summary of the DMA results (for 32 pph DDS) with increasing wt % PBAE
shows a small increase in the Tg and a small decrease in the storage modulus. Specimens with
25 wt % PBAE exhibited complete phase inversion which led to more substantial decrease
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in modulus. However, the Tg continued the slightly upward trend.
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Figure E.10: Summary of DMA results. (a) Glass transition temperature for both EPON
828:DDS and 20 wt % PBAE in EPON 828: DDS. A 40◦C improvement was observed by
using the stoichiometric amine ratio of 32 pph. (b) Summary of DMA results for 32 pph
DDS showing a gradual increase in Tg, but a small decrease in modulus.
Despite the increase in Tg, little change was observed in the virgin fracture toughness
and healing performance. Three specimen types are shown in Figure E.11: Type I refer-
ence tests (heat), Type II reference tests (solvent), and in situ self-healing specimens with
microcapsules. For Type I reference tests, specimens were heated for 1 h at 130◦C (the
healing cycle used by Hayes et al. [77]). As discussed in Chapter 6, since the Tg of the
material with 25 pph DDS was relatively low, the healing by heat was very effective. The
healing performance was similar to that of the Type II reference tests using solvent. For
Type II reference tests, 5 µl of EPA was injected into the crack plane and specimens were
allowed to heal a minimum of 2 d up to 8 d. After 2 d the healing performance began to
plateau. Type II reference tests with 32 pph DDS showed little change in performance. For
the in situ specimens, PU/UF microcapsules were added directly to the matrix material
(15 wt % microcapsules in the 15 wt %PBAE specimens and 10 wt % microcapsules in the
20 wt % PBAE specimens). A high loading was initially explored to allow maximum healing,
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but this capsule loading was eventually reduced when microcapsule stability was improved
(Chapter 6).
a b
Figure E.11: Summary of TDCB results with 25 pph DDS compared to Type II reference
samples with 32 pph DDS for (a) 15 wt % PBAE and (b) 20 wt % PBAE.
E.3.4 TDCB Calibration with PBAE-toughened Epoxy
The TDCB specimen geometry (Figure E.12) has been widely used in self-healing materials
research due to its crack length independence. However, in this study the use of a solvated,
and therefore potentially ductile, thermoplastic as the healing agent made the author ques-
tion the calculation of healing efficiency. In prior work, ductility has been addressed by
using an alternative calculation of healing efficiency, η′. To use this metric, the relationship
between compliance and crack length is required. While this relationship has been calcu-
lated for EPON 828: DETA, the thermoplastic additive changed this relationship (as seen
below). More research is needed to reduce scatter enough to rely on this measurement for
healing efficiency calculations. Additionally, a paper by Ikeda et al. [114] showed that due
to the large amount of elastic energy held by the adherends in the TDCB geometry, elastic
and elastic-plastic analyses gave similar results. From this result, the traditional definition
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of healing efficiency, η, was used in this work. For completeness, the calibration conducted
is given below.
(a)
(b)
(a)
8
Figure E.12: (a) TDCB specimen geometry and (b) height profile matched with the implicit
solution for h(a) adapted from Brown [115].
By careful selection of geometry, fracture toughness, KIC, can be defined as the critical
fracture load, PC multiplied by a constant, α:
KIC = αPC (E.2)
where α is defined as:
α = 2
√
m
bnb
. (E.3)
Following the analysis outlined in depth by Brown [115], α, is calculated from geometric
constants from Figure E.12a and m, which is derived from beam theory. The relationship
between m, crack length, a, the TDCB height profile, h and Poisson’s ratio, ν is given by
Equation E.4:
m =
3a2
h3
+
6
8
(1 +
ν
2
)
1
h
= mtheory. (E.4)
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The implicit solution to this equation is shown graphically in Figure E.12b where mtheory
= 0.48 mm-1. Using this value for m, α=11.2 x 103 m-3/2. The value for m can also be
determined experimentally by Equation E.5:
m =
Eb
8
dC
da
= mexp. (E.5)
Ideally these two values would be identical, but this is not common in reality. Brown
[115] performed a set of calibration experiments to determine dC
da
for EPON 828: DETA, a
common epoxy in self-healing research, and a similar study was completed here to calibrate
TDCB experiments for a thermoplastic-toughened epoxy. A summary of the values for α,
m, and the corresponding fracture toughness, KIC for each wt % of PBAE is shown in
Table E.2. In each case, optical images were taken as the crack progressed and matched
with the specimen’s compliance obtained by fitting the slope of each segment on the load
displacement curve (Figure E.13a). Compliance as a function of crack length was plotted
for multiple specimens and a line was fitted to define dC
da
(Figure E.13b).
Table E.2: Summary of TDCB calibration experiments and variation in KIC.
wt.% KICtheory mexp αexp KICexp
PBAE (MPa m0.5) (mm-1) (m-3/2) (MPa m0.5)
0 0.30 ± 0.05
10 0.56 ± 0.04
15 0.78 ± 0.04 0.72 13.5 x 103 0.95 ± 0.05
20 0.96 ± 0.03 0.78 14.1 x 103 1.2 ± 0.05
E.3.5 Methods to Improve Healing Performance
Even with optimization of the experimental protocol, full recovery of fracture toughness was
not achieved. Four methods to improve healing performance were explored: use of adhesion
promotors, the blending of a polymer into the solvent healing agent, a reduction in the
crack separation and the addition of heat. In prior work, adhesion promotors have been
added directly to the matrix material to later aid in the healing process [14, 20]. Due to the
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Figure E.13: (a) Load-displacement curve for a 20 wt % PBAE specimen. A horizontal
dashed line calls out the value for Pc used in calculation of KIC. Fitted dashed lines to
each slope on the load-displacement curve represent the inverse of compliance values. Cor-
responding images are used to find crack lengths for each of the slopes shown. The values of
compliance versus crack length are shown in (b) for three specimens (20 wt % PBAE). The
change in compliance with crack length is obtained by fitting a line through that data.
similarity of the thermoplastic PBAE to epoxy, an adhesion promotor that would lie dormant
during a high temperature cure cycle and then promote adhesion of the thermoplastic PBAE
to the epoxy substrate was not found by this author. There may be a way to protect an
adhesion promotor, but the author suspects any adhesion promotor added directly into the
matrix would prefer to go to the interface between the thermoplastic and epoxy during the
cure cycle instead of remaining reactive for later use.
The second method explored to improve healing performance was adding a polymer to
the healing agent. Early studies looked at incorporating the thermoplastic, PBAE, into EPA
during encapsulation. However, this thermoplastic interfered with the shell wall formation
and decreased the thermal stability. Several polymers with various molecular weights were
also explored as additives, in an attempt to improve the continuity of the healed film. Un-
fortunately, minimal to no improvement was observed from the addition of several polymers
soluble in EPA (Figure E.14). The large reduction in healing performance as molecular
weight increased could be related to poor mixing/ blending between the PBAE (MW=40
kDa) and the polymer additive.
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Figure E.14: The effect of the addition of 10 wt % polymer into the EPA healing agent on
healed fracture toughness for TDCB specimens with 20 wt % PBAE. Increases in molecular
weight led to reduced healing performance.
The last method investigated was the effect of decreasing the crack separation. In prior
work by Caruso et al. [27], crack separations were relatively small (ca. 3-8 µm), which
is advantageous for healing dependent on capillary forces. Due to the dual toughening by
microcapsules and the thermoplastic, the maximum crack separations observed in the TDCB
specimens (after virgin testing) were on the order of 50 µm (Figure E.15).
50 µm
Figure E.15: SEM image of crack separation in a TDCB specimen with 20 wt % PBAE.
To see if decreasing the crack separation would increase the healing performance, some
TDCB specimens were unloaded before the crack reached the end of the groove and then
injected with EPA. No improvement in healing performance was observed. As a final check,
double cleavage drilled compression (DCDC) specimens were prepared since the DCDC
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geometry typically achieves small crack separations. After initial fracture, these specimens
were injected with EPA and allowed to heal at RT for various amounts of time. Even with
6 d of healing time and an additional clamp to reduce the crack separation to the 3-8 µm
range, the healing performance was still not 100% (Figure E.16).
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Figure E.16: Representative load displacement curve of a DCDC specimen (20 wt % PBAE)
after 6 d of healing with a clamp to reduce crack separation. Healing performance was not
significantly improved by the decrease in crack separation.
The last attempt to improve healing performance was to use heat to drive out residual
solvent. The hypothesis that residual solvent plasticized and reduced the mechanical prop-
erties of the thermoplastic was explored by the addition of a thermal cycle to the healing
process. After the virgin testing, 24 h was allotted for the solvent to dissolve and redistribute
the thermoplastic. Then the TDCB specimens were subjected to a thermal cycle of 50◦C
for 24 h. This temperature was below the Tg of PBAE (90
◦C), but elevated to expedite the
removal of solvent. A temperature below Tg was selected to ensure no improvements were
due to melting of the thermoplastic. However, this thermal cycle also did not lead to full
recovery of fracture toughness.
Due to each of these failed attempts, the author suspects the main limitation in this
healing system is the lack of bonding between the thermoplastic healing agent and the
fully cured epoxy. Indeed, when a TDCB specimen (20 wt % PBAE) was injected with a 1:1
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solution of EPA and the stoichiometric mixture of EPON 813: EPIKURE 3233 (the two part
healing epoxy chemistry used by Jin et al. [24]), full recovery was observed (Figure E.17).
The combination of three microcapsules (amine, resin and solvent) would be a complicated
system, though a possible direction in future work. An additional obstacle is the relatively
low thermal stability of amine microcapsules in epoxy matrices.
Figure E.17: Load displacement curve of a TDCB specimen injected with a 1:1 solution
of EPA and the stoichiometric mixture of EPON 813: EPIKURE 3233 (the healing epoxy
system used by Jin et al. [24]. Full recovery is achieved due to the repair of both phases of
the matrix material.
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